CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
13906408,1390640851,51,F,,20230905,20170825,20230914,EXP,,CA-009507513-0809CAN00001,MERCK,"Harris M, Larsen G, Montaner JSG. Exacerbation of depression associated with starting raltegravir: a report of four cases.. AIDS. 2008;22(14):1890-2",54,YR,,M,Y,,,20230914,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Diplopia;Drug interaction;Eyelid ptosis;Incorrect route of product administration;Intentional product use issue;Lipodystrophy acquired;Loss of personal independence in daily activities;Mitochondrial toxicity;Off label use;Paranoia;Prescribed overdose;Product use in unapproved indication;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,1390640851,DE,,,1390640851,1,20070620,,,,1390640851,1,HIV infection
15474937,154749372,2,F,,20230719,20181008,20230729,EXP,,US-TEVA-2018-US-961730,TEVA,,,,A,M,Y,,,20230730,,PH,US,US,Efavirenz/emtricitabine/tenofovir desoproxil,Hepatotoxicity;Intentional product misuse,154749372,OT,,,,,,,,,154749372,1,Product used for unknown indication
15573679,1557367911,11,F,,20230914,20181101,20230922,EXP,,CA-TEVA-2018-CA-968128,TEVA,,54,YR,A,M,Y,,,20230922,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,1557367911,OT,,,,,,,,,1557367911,1,HIV infection
15897393,158973933,3,F,20090119,20230913,20190131,20230918,EXP,,US-GILEAD-2019-0387829,GILEAD,,58,YR,A,M,Y,72.562,KG,20230918,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Economic problem;Emotional distress;Fear;Osteopenia;Osteoporosis;Pain;Stress,158973933,OT,,,158973933,1,2001,200705,,,158973933,1,HIV infection
15920730,159207303,3,F,20140801,20230921,20190205,20230927,EXP,,US-GILEAD-2019-0387816,GILEAD,,61,YR,A,M,Y,,,20230927,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone demineralisation;Chronic kidney disease;Depression;Economic problem;Emotional distress;Loss of libido;Loss of personal independence in daily activities;Osteopenia;Pain;Renal impairment,159207303,OT,,,159207303,1,201310,201510,,,159207303,1,HIV infection
16837681,168376813,3,F,20110901,20230914,20190923,20230921,EXP,,US-GILEAD-2019-0429593,GILEAD,,67,YR,E,M,Y,,,20230921,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Decreased activity;Economic problem;Emotional distress;Insomnia;Loss of personal independence in daily activities;Osteopenia;Osteoporosis;Pain;Quality of life decreased,168376813,OT,,,168376813,1,2001,20080110,56,DAY,168376813,1,HIV infection
16851521,168515214,4,F,20150101,20230914,20190925,20230921,EXP,,US-GILEAD-2019-0429645,GILEAD,,25,YR,A,M,Y,135,KG,20230921,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Cardiac failure congestive;Chronic kidney disease;Decreased activity;Depressed mood;Emotional distress;End stage renal disease;Fatigue;Gait disturbance;Impaired work ability;Loss of personal independence in daily activities;Nephropathy;Pain;Panic attack;Peripheral swelling;Pneumonia;Quality of life decreased;Renal failure;Sepsis,168515214,HO,,,168515214,1,2005,2011,,,168515214,1,HIV infection
17313822,173138225,5,F,20140101,20230926,20200124,20230928,EXP,,US-GILEAD-2020-0448025,GILEAD,,,,A,M,Y,104.3,KG,20230928,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Disturbance in attention;Eating disorder;Economic problem;Emotional distress;End stage renal disease;Fatigue;Pain;Renal disorder;Renal failure;Sexual dysfunction;Sleep apnoea syndrome;Sleep disorder,173138225,OT,,,173138225,1,20120209,201601,26,DAY,173138225,1,HIV infection
17324065,173240657,7,F,20090909,20230913,20200127,20230918,EXP,,US-GILEAD-2020-0448201,GILEAD,,30,YR,A,F,Y,64.853,KG,20230918,,LW,US,US,SUSTIVA,Acute kidney injury;Anxiety;Blood creatinine increased;Chronic kidney disease;Depression;End stage renal disease;Renal injury,173240657,HO,,,173240657,1,200605,201912,1759,DAY,173240657,1,HIV infection
17353136,173531363,3,F,20131001,20230911,20200131,20230914,EXP,,US-GILEAD-2020-0448717,GILEAD,,48,YR,A,M,Y,68.027,KG,20230914,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure,173531363,HO,,,173531363,1,2011,20130321,1099,DAY,173531363,1,HIV infection
17353480,173534805,5,F,20110101,20230911,20200131,20230918,EXP,,US-GILEAD-2020-0448802,GILEAD,,,,A,F,Y,,,20230918,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure,173534805,OT,,,173534805,1,2004,,,,173534805,1,HIV infection
17497526,174975267,7,F,20060101,20230808,20200304,20230811,EXP,,US-GILEAD-2020-0452918,GILEAD,,42,YR,A,M,Y,70.748,KG,20230811,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Glomerulonephritis chronic;Pain;Renal failure;Renal tubular necrosis,174975267,HO,,,174975267,1,2006,201808,86,DAY,174975267,1,HIV infection
17579634,175796344,4,F,20171101,20230911,20200325,20230914,EXP,,US-GILEAD-2020-0455880,GILEAD,,46,YR,A,F,Y,162.36,KG,20230914,,LW,US,US,SUSTIVA,Acute kidney injury;Anaemia;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Pain,175796344,OT,,,175796344,1,201205,201711,,,175796344,1,HIV infection
17714453,177144537,7,F,20040617,20230919,20200427,20230922,EXP,,US-GILEAD-2020-0460865,GILEAD,,33,YR,A,M,Y,73.016,KG,20230922,,LW,US,US,SUSTIVA,Acute kidney injury;Anxiety;Chronic kidney disease;Emotional distress;End stage renal disease;Hyperparathyroidism secondary;Mobility decreased;Pain;Renal cyst;Renal failure;Renal tubular necrosis,177144537,OT,,,177144537,1,20040112,20171023,5033,DAY,177144537,1,HIV infection
17721939,177219395,5,F,20050101,20230808,20200429,20230814,EXP,,US-GILEAD-2020-0462221,GILEAD,,,,A,M,Y,81.63,KG,20230814,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Bone pain;Emotional distress;Exercise tolerance decreased;Gait disturbance;Multiple fractures;Muscular weakness;Osteonecrosis;Osteoporosis;Pain;Renal impairment;Renal injury;Skeletal injury,177219395,OT,,,177219395,1,2001,2002,,,177219395,1,HIV infection
17732677,177326776,6,F,20070101,20230818,20200501,20230912,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK074404,GLAXOSMITHKLINE,,,,,,Y,,,20230912,,MD,CA,CA,SUSTIVA,Drug interaction;Psychiatric decompensation,177326776,HO,,,177326776,2,2007,,,,177326776,1,Depression
18043574,180435747,7,F,20100801,20230818,20200720,20230822,EXP,,US-GILEAD-2020-0483861,GILEAD,,59,YR,A,M,Y,175,KG,20230822,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Bone pain;Dysstasia;Emotional distress;Gait disturbance;Osteoporosis;Pain;Pollakiuria;Renal failure;Renal impairment;Tooth loss,180435747,OT,,,180435747,1,200708,2018,,,180435747,1,HIV infection
18074485,180744853,3,F,,20230907,20200727,20230912,EXP,,US-GILEAD-2020-0485549,GILEAD,,,,A,M,Y,86.168,KG,20230912,,LW,US,US,SUSTIVA,Acute kidney injury;Acute respiratory failure;Anaemia;Chronic kidney disease;Craniocerebral injury;Emotional distress;End stage renal disease;Metabolic acidosis;Pain;Renal failure;Status epilepticus,180744853,HO,,,180744853,1,2010,2017,,,180744853,1,HIV infection
18156798,181567983,3,F,20050101,20230922,20200817,20230928,EXP,,US-GILEAD-2020-0490398,GILEAD,,51,YR,A,F,Y,246,KG,20230928,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone demineralisation;Depression;Emotional distress;Osteopenia;Osteoporosis;Pain;Renal impairment,181567983,OT,,,181567983,1,2005,200908,,,181567983,1,HIV infection
18157575,181575754,4,F,20180101,20230825,20200817,20230830,EXP,,US-GILEAD-2020-0490404,GILEAD,,,,A,F,Y,113.38,KG,20230830,,LW,US,US,SUSTIVA,Anxiety;Bone density decreased;Depression;Emotional distress;Osteoporosis;Pain,181575754,OT,,,181575754,1,2008,2016,,,181575754,1,HIV infection
18158162,181581624,4,F,20070605,20230925,20200817,20230929,EXP,,US-GILEAD-2020-0489414,GILEAD,,43,YR,A,M,Y,,,20230929,,LW,US,US,EFAVIRENZ,Anxiety;Chronic kidney disease;Emotional distress;Pain;Renal impairment,181581624,OT,,,181581624,1,2009,201001,,,181581624,1,HIV infection
18517808,185178084,4,F,20120120,20230720,20201118,20230726,PER,,US-GILEAD-2020-0503385,GILEAD,,38,YR,A,M,Y,77.098,KG,20230726,,LW,US,US,SUSTIVA,Blood creatinine increased;Nephropathy;Renal cyst;Renal failure,185178084,OT,,,185178084,1,2004,2016,1945,DAY,185178084,1,HIV infection
18886499,188864992,2,F,,20230901,20210212,20230905,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013564,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20230905,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,188864992,OT,,,,,,,,,188864992,1,Product used for unknown indication
19224072,192240723,3,F,20070101,20230914,20210505,20230918,PER,,US-GILEAD-2021-0527891,GILEAD,,50,YR,A,M,Y,95.238,KG,20230918,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Depression;Emotional distress;Osteopenia;Pain;Post-traumatic stress disorder,,,,,192240723,1,200709,201203,1728,DAY,192240723,1,HIV infection
19433699,194336993,3,F,20160501,20230720,20210617,20230726,PER,,US-GILEAD-2021-0536633,GILEAD,,59,YR,A,M,Y,77.11,KG,20230726,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Emotional distress;Pain;Pollakiuria;Renal failure;Renal impairment,194336993,OT,,,194336993,1,2012,201605,,,194336993,1,HIV infection
19435745,194357453,3,F,20160101,20230808,20210618,20230815,EXP,,US-GILEAD-2021-0536637,GILEAD,,,,A,M,Y,,,20230815,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density abnormal;Cardiac disorder;Depression;Dysstasia;Emotional distress;Osteopenia;Osteoporosis;Pain;Protein urine present;Proteinuria;Renal impairment;Renal injury,194357453,OT,,,194357453,1,2007,201605,,,194357453,1,HIV infection
19455864,194558643,3,F,20080501,20230914,20210624,20230920,EXP,,US-GILEAD-2021-0537463,GILEAD,,41,YR,A,M,Y,100.69,KG,20230920,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;End stage renal disease;Hyperparathyroidism secondary;Nephrogenic anaemia;Pain;Renal failure,194558643,OT,,,194558643,1,2006,200810,,,194558643,1,HIV infection
19455876,194558763,3,F,20140101,20230808,20210624,20230811,EXP,,US-GILEAD-2021-0537450,GILEAD,,,,A,M,Y,79.4,KG,20230811,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Arthralgia;Bone density decreased;Dysstasia;Emotional distress;Gait disturbance;Hand fracture;Pain,194558763,OT,,,194558763,1,2009,201312,,,194558763,1,HIV infection
19455918,194559183,3,F,20130101,20230731,20210624,20230804,EXP,,US-GILEAD-2021-0537601,GILEAD,,41,YR,A,M,Y,90.703,KG,20230804,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Emotional distress;Osteopenia;Osteoporosis;Pain,194559183,OT,,,194559183,1,2009,2020,,,194559183,1,HIV infection
19457453,194574533,3,F,20140101,20230724,20210624,20230728,EXP,,US-GILEAD-2021-0537381,GILEAD,,,,A,F,Y,127,KG,20230728,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Arthralgia;Arthritis;Bone density decreased;Dysstasia;Emotional distress;Foot fracture;Gait disturbance;Osteoporosis;Pain;Pain in extremity,194574533,OT,,,194574533,1,2001,2008,,,194574533,1,HIV infection
19465512,194655123,3,F,20120101,20230731,20210624,20230803,EXP,,US-GILEAD-2021-0537424,GILEAD,,,,A,F,Y,99.33,KG,20230803,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Gait disturbance;Hypertension;Osteopenia;Pain;Patella fracture;Renal injury;Rib fracture;Schizophrenia;Spinal fracture,194655123,OT,,,194655123,1,2009,2016,,,194655123,1,HIV infection
19516890,195168904,4,F,20050101,20230807,20210711,20230809,EXP,,US-GILEAD-2021-0539492,GILEAD,,,,A,M,Y,83.914,KG,20230809,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Decreased activity;Decreased interest;Depressed mood;Emotional distress;Multiple fractures;Pain;Stress;Tibia fracture,195168904,OT,,,195168904,1,2008,201908,,,195168904,1,HIV infection
19593176,195931763,3,F,20150101,20230810,20210722,20230815,PER,,US-GILEAD-2021-0541373,GILEAD,,,,A,M,Y,113.39,KG,20230815,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;Pain;Pollakiuria;Renal failure,195931763,OT,,,195931763,1,2002,2004,,,195931763,1,HIV infection
19654378,196543783,3,F,20080101,20230912,20210804,20230918,EXP,,US-GILEAD-2021-0542326,GILEAD,,,,A,M,Y,,,20230918,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Gout;Hypertension;Mobility decreased;Pain;Pneumonia;Seizure,196543783,OT,,,196543783,1,2001,201608,,,196543783,1,HIV infection
19654911,196549113,3,F,20100101,20230804,20210804,20230808,EXP,,US-GILEAD-2021-0542389,GILEAD,,,,A,F,Y,90.703,KG,20230808,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Depression;Emotional distress;Gait disturbance;Impaired work ability;Osteoporosis;Pain;Protein urine present;Renal cyst;Renal impairment;Sitting disability,196549113,OT,,,196549113,1,2009,201406,,,196549113,1,HIV infection
19720476,197204763,3,F,20111201,20230801,20210819,20230803,EXP,,US-GILEAD-2021-0544324,GILEAD,,42,YR,A,M,Y,49.887,KG,20230803,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Bone density decreased;Bone pain;Emotional distress;Hip fracture;Hypertension;Insomnia;Lower limb fracture;Lumbar vertebral fracture;Multiple fractures;Osteopenia;Osteoporosis;Pain;Rib fracture;Spinal fracture;Wrist fracture,197204763,OT,,,197204763,1,2008,201904,,,197204763,1,HIV infection
19755697,197556973,3,F,20140901,20230807,20210827,20230810,EXP,,US-GILEAD-2021-0545324,GILEAD,,64,YR,A,M,Y,,,20230810,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Erectile dysfunction;Gout;Hypertension;Pain;Renal failure,197556973,OT,,,197556973,1,2006,2016,,,197556973,1,HIV infection
19766166,197661667,7,F,20150301,20230914,20210831,20230928,PER,,US-GILEAD-2021-0545320,GILEAD,,63,YR,A,F,Y,58.957,KG,20230928,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Arthropathy;Asthenia;Body height decreased;Bone density decreased;Bone pain;Emotional distress;Fatigue;General physical health deterioration;Mobility decreased;Osteopenia;Osteoporosis;Pain;Therapy non-responder,197661667,OT,,,197661667,1,2007,20200901,2567,DAY,197661667,1,HIV infection
19795983,197959833,3,F,20090801,20230809,20210907,20230814,EXP,,US-GILEAD-2021-0547308,GILEAD,,54,YR,A,F,Y,105.67,KG,20230814,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Hyperlipidaemia;Mobility decreased;Osteopenia;Pain;Wrist fracture,197959833,OT,,,197959833,1,2003,200806,,,197959833,1,HIV infection
19800129,198001293,3,F,20160101,20230926,20210908,20230928,PER,,US-GILEAD-2021-0547348,GILEAD,,,,A,M,Y,98.413,KG,20230927,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone density decreased;Depression;Emotional distress;Gait disturbance;Osteopenia;Pain;Renal disorder;Somnolence,,,,,198001293,1,2015,201505,,,198001293,1,HIV infection
19806698,198066983,3,F,20080101,20230809,20210909,20230815,EXP,,US-GILEAD-2021-0547384,GILEAD,,,,A,F,Y,70.295,KG,20230815,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Arthritis;Back pain;Bone density decreased;Emotional distress;Osteopenia;Osteoporosis;Pain,198066983,OT,,,198066983,1,2003,201601,,,198066983,1,HIV infection
19809327,198093273,3,F,20100301,20230703,20210909,20230706,EXP,,US-GILEAD-2021-0547292,GILEAD,,44,YR,A,M,Y,80.272,KG,20230706,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Bone density decreased;Bone pain;Decreased activity;Depression;Emotional distress;Hyperlipidaemia;Osteoporosis;Pain,198093273,OT,,,198093273,1,2001,2004,,,198093273,1,HIV infection
19823132,198231324,4,F,20150701,20230824,20210913,20230830,EXP,,US-GILEAD-2021-0547356,GILEAD,,53,YR,A,M,Y,75.737,KG,20230830,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Chronic kidney disease;Compression fracture;Emotional distress;Gait disturbance;Mobility decreased;Multiple fractures;Osteopenia;Pain,198231324,OT,,,198231324,1,2010,201701,,,198231324,1,HIV infection
19855618,198556183,3,F,20170101,20230810,20210920,20230816,EXP,,US-GILEAD-2021-0548487,GILEAD,,,,A,M,Y,,,20230816,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Depression;Emotional distress;Femur fracture;Osteoporosis;Pain;Rib fracture,198556183,OT,,,198556183,1,2006,2019,,,198556183,1,HIV infection
19879103,198791032,2,F,,20230714,20210924,20230728,EXP,,SE-AUROBINDO-AUR-APL-2021-015949,AUROBINDO,"Tyrberg E, Eden A, Eriksen J, Nilsson S, Treutiger CJ, Thalme A, et al.. Higher plasma drug levels in elderly people living with HIV treated with darunavir.. PLOS ONE.. 2021;16 (2).:e0246171 (1-11)",66,YR,,M,Y,,,20230728,,HP,SE,SE,EFAVIRENZ,Potentiating drug interaction,198791032,OT,,,,,,,,,198791032,1,Product used for unknown indication
19938893,1993889320,20,F,,20230816,20211011,20230825,EXP,,CA-MYLANLABS-11P-028-0710272-00,MYLAN,,54,YR,,M,Y,,,20230825,,CN,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,1993889320,HO,,,,,,,,,1993889320,1,Bipolar disorder
19947474,199474745,5,F,20160401,20230701,20211012,20230705,EXP,,US-GILEAD-2021-0551967,GILEAD,,50,YR,A,M,Y,82.54,KG,20230705,,LW,US,US,SUSTIVA,Abdominal discomfort;Anhedonia;Anxiety;Asthenia;Chronic kidney disease;Emotional distress;Fatigue;Libido decreased;Loss of personal independence in daily activities;Nausea;Pain;Renal impairment,199474745,OT,,,199474745,1,2001,2004,,,199474745,1,HIV infection
20041003,200410034,4,F,20070901,20230703,20211107,20230705,EXP,,US-GILEAD-2021-0555190,GILEAD,,42,YR,A,M,Y,81.633,KG,20230705,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Blood creatinine increased;Chronic kidney disease;Emotional distress;Fatigue;Osteopenia;Osteoporosis;Pain;Protein urine present;Renal failure;Renal impairment;Vitamin D deficiency,200410034,HO,,,200410034,1,2006,2018,,,200410034,1,HIV infection
20113979,201139793,3,F,20120101,20230813,20211125,20230817,EXP,,US-GILEAD-2021-0557438,GILEAD,,,,A,F,Y,68.481,KG,20230817,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Chronic kidney disease;Dysstasia;Emotional distress;Loss of personal independence in daily activities;Mobility decreased;Osteoporosis;Pain,201139793,OT,,,201139793,1,2001,2004,,,201139793,1,HIV infection
20118774,201187743,3,F,20100401,20230701,20211126,20230704,EXP,,US-GILEAD-2021-0557192,GILEAD,,51,YR,A,M,Y,100.23,KG,20230704,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Asthenia;Blood creatinine increased;Chronic kidney disease;Emotional distress;End stage renal disease;Fatigue;Loss of personal independence in daily activities;Mobility decreased;Pain;Renal failure,201187743,HO,,,201187743,1,2004,200701,,,201187743,1,HIV infection
20124059,201240593,3,F,20160401,20230918,20211129,20230922,EXP,,US-GILEAD-2021-0557458,GILEAD,,50,YR,A,M,Y,76.644,KG,20230922,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Asthenia;Bone demineralisation;Emotional distress;Fatigue;Foot fracture;Loss of personal independence in daily activities;Osteoporosis;Pain,201240593,OT,,,201240593,1,2013,201703,,,201240593,1,HIV infection
20128073,201280733,3,F,20090501,20230724,20211129,20230726,EXP,,US-GILEAD-2021-0557457,GILEAD,,40,YR,A,F,Y,68.027,KG,20230726,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Back pain;Bone demineralisation;Depression;Emotional distress;Fall;Gait disturbance;Hip fracture;Lower limb fracture;Mobility decreased;Osteonecrosis;Osteoporosis;Pain;Renal impairment,201280733,OT,,,201280733,1,2004,200906,,,201280733,1,HIV infection
20132091,201320913,3,F,20170201,20230809,20211130,20230814,EXP,,US-GILEAD-2021-0557164,GILEAD,,51,YR,A,M,Y,90.703,KG,20230814,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Cardiac disorder;Chronic kidney disease;Dyspnoea;Emotional distress;Gait disturbance;Musculoskeletal disorder;Pain,201320913,OT,,,201320913,1,2006,2020,,,201320913,1,HIV infection
20138679,201386795,5,F,20170101,20230731,20211202,20230802,PER,,US-GILEAD-2021-0557128,GILEAD,,,,A,M,Y,92.971,KG,20230802,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;CD4 lymphocytes decreased;Chronic kidney disease;Emotional distress;Micturition disorder;Pain;Proteinuria;Renal impairment,201386795,OT,,,201386795,1,2001,2017,,,201386795,1,HIV infection
20149844,201498443,3,F,20100901,20230712,20211206,20230717,EXP,,US-GILEAD-2021-0557165,GILEAD,,61,YR,A,M,Y,82.086,KG,20230717,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Dysuria;Emotional distress;Glomerulonephritis;Pain;Pollakiuria,201498443,OT,,,201498443,1,2001,2004,,,201498443,1,HIV infection
20150086,201500864,4,F,20131201,20230725,20211206,20230728,EXP,,US-GILEAD-2021-0557126,GILEAD,,55,YR,A,M,Y,79.37,KG,20230728,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Bone pain;Chronic kidney disease;Depression;Emotional distress;Insomnia;Osteopenia;Pain;Patella fracture;Pneumonia;Pollakiuria;Renal failure;Renal injury;Urinary tract infection;Weight increased,201500864,HO,,,201500864,1,2015,2017,,,201500864,1,HIV infection
20152924,201529247,7,F,20170301,20230724,20211206,20230801,EXP,,US-GILEAD-2021-0557543,GILEAD,,54,YR,A,M,Y,99.773,KG,20230801,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Apathy;Chronic kidney disease;Drug ineffective;Emotional distress;Insomnia;Pain,201529247,OT,,,201529247,1,2003,200501,,,201529247,1,HIV infection
20159148,201591483,3,F,20141201,20230807,20211208,20230810,EXP,,US-GILEAD-2021-0557366,GILEAD,,52,YR,A,M,Y,58.05,KG,20230810,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Asthenia;Chronic kidney disease;Emotional distress;End stage renal disease;Hypertension;Pain;Weight decreased,201591483,OT,,,201591483,1,2006,2011,,,201591483,1,HIV infection
20161207,201612073,3,F,20180101,20230807,20211208,20230809,PER,,US-GILEAD-2021-0557433,GILEAD,,,,A,M,Y,97.506,KG,20230809,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Depression;Dysstasia;Emotional distress;Gait disturbance;General physical health deterioration;Mobility decreased;Osteopenia;Pain,,,,,201612073,1,2005,201306,,,201612073,1,HIV infection
20217592,2021759210,10,F,20211120,20230821,20211222,20230823,EXP,,DE-TAKEDA-2021TUS079245,TAKEDA,,56,YR,,M,Y,,,20230823,,HP,DE,DE,EFAVIRENZ,C-reactive protein increased;Femur fracture,2021759210,DS,,,2021759210,1,20190107,20211227,38,DAY,2021759210,1,Factor VIII deficiency
20220620,202206203,3,F,20100101,20230725,20211223,20230728,EXP,,US-GILEAD-2021-0561983,GILEAD,,,,A,M,Y,61.224,KG,20230728,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Degenerative bone disease;Emotional distress;Femoral neck fracture;Fracture;Hip fracture;Multiple fractures;Musculoskeletal procedural complication;Osteopenia;Osteoporosis;Pain;Shoulder fracture,202206203,OT,,,202206203,1,2006,2014,,,202206203,1,HIV infection
20222028,202220283,3,F,,20230810,20211223,20230816,EXP,,US-GILEAD-2021-0561992,GILEAD,,,,A,M,Y,57.143,KG,20230816,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Bone demineralisation;Depression;Dysstasia;Emotional distress;Osteoporosis;Pain;Pain in extremity,202220283,OT,,,202220283,1,2014,201104,,,202220283,1,HIV infection
20230602,202306023,3,F,20161201,20230815,20211227,20230817,EXP,,US-GILEAD-2021-0562338,GILEAD,,51,YR,A,M,Y,115.19,KG,20230817,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Back pain;Chronic kidney disease;Emotional distress;Gait disturbance;Oedema peripheral;Pain;Pollakiuria;Renal impairment;Renal injury,202306023,OT,,,202306023,1,2001,201210,,,202306023,1,HIV infection
20296649,202966493,3,F,20060101,20230801,20220105,20230804,EXP,,US-GILEAD-2022-0563759,GILEAD,,,,A,M,Y,106.12,KG,20230804,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Pain,202966493,OT,,,202966493,1,2006,201707,,,202966493,1,HIV infection
20303394,203033943,3,F,20170101,20230921,20220106,20230928,EXP,,US-GILEAD-2022-0563765,GILEAD,,45,YR,A,F,Y,88.904,KG,20230928,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Arthralgia;Chronic kidney disease;Depression;Emotional distress;Femur fracture;Gait disturbance;Loss of personal independence in daily activities;Mobility decreased;Nausea;Osteoporosis;Pain;Renal failure,203033943,HO,,,203033943,1,2009,201902,,,203033943,1,HIV infection
20303409,203034093,3,F,20140101,20230808,20220106,20230811,EXP,,US-GILEAD-2022-0563851,GILEAD,,,,A,F,Y,81.633,KG,20230811,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Emotional distress;Osteopenia;Osteoporosis;Pain,203034093,OT,,,203034093,1,2004,2016,,,203034093,1,HIV infection
20303504,203035043,3,F,20140101,20230707,20220106,20230712,EXP,,US-GILEAD-2022-0563909,GILEAD,,60,YR,A,F,Y,247,KG,20230712,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Balance disorder;Chronic kidney disease;Cognitive disorder;Depression;Emotional distress;Hyperparathyroidism;Pain;Renal injury;Skeletal injury,203035043,OT,,,203035043,1,2006,2013,,,203035043,1,HIV infection
20304149,203041493,3,F,20120120,20230721,20220106,20230727,EXP,,US-VIIV HEALTHCARE LIMITED-US2020262122,VIIV,,,,,,Y,,,20230727,,LW,COUNTRY NOT SPECIFIED,US,SUSTIVA,Blood creatinine increased;Nephropathy;Renal cyst;Renal failure,203041493,OT,,,203041493,1,20130129,20130314,44,DAY,203041493,1,HIV infection
20305983,203059833,3,F,20160101,20230804,20220106,20230809,EXP,,US-GILEAD-2022-0563902,GILEAD,,63,YR,A,M,Y,65.306,KG,20230809,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone demineralisation;Chronic kidney disease;Emotional distress;Foot fracture;General physical health deterioration;Hypertension;Ill-defined disorder;Neck injury;Osteoporosis;Pain;Renal failure,203059833,OT,,,203059833,1,2004,201705,,,203059833,1,HIV infection
20306374,203063743,3,F,20170801,20230920,20220106,20230924,EXP,,US-GILEAD-2022-0563771,GILEAD,,62,YR,A,M,Y,90.703,KG,20230924,,LW,US,US,SUSTIVA,Acute kidney injury;Anaemia;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Enzyme level increased;Pain;Renal disorder;Renal injury,203063743,OT,,,203063743,1,2006,201812,,,203063743,1,HIV infection
20339020,203390203,3,F,20140101,20230816,20220117,20230821,EXP,,US-GILEAD-2022-0565390,GILEAD,,,,E,M,Y,58.957,KG,20230821,,LW,US,US,SUSTIVA,Acidosis;Acute kidney injury;Anaemia;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Fanconi syndrome acquired;General physical health deterioration;Osteoporosis;Pain,203390203,OT,,,203390203,1,2012,201612,,,203390203,1,HIV infection
20349004,203490043,3,F,20100101,20230725,20220119,20230728,EXP,,US-GILEAD-2022-0565450,GILEAD,,,,A,M,Y,64.399,KG,20230728,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Blood creatinine increased;Bone demineralisation;Chronic kidney disease;Emotional distress;Fanconi syndrome acquired;Fatigue;Hypophosphataemia;Multiple fractures;Osteopenia;Osteoporosis;Pain;Rib fracture;Vitamin D deficiency,203490043,OT,,,203490043,1,2007,2015,,,203490043,1,HIV infection
20351646,203516463,3,F,20060101,20230803,20220119,20230808,EXP,,US-GILEAD-2022-0565657,GILEAD,,,,A,F,Y,74.376,KG,20230808,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Back pain;Cardiac disorder;Chronic kidney disease;Degenerative bone disease;Emotional distress;Exercise tolerance decreased;Gait disturbance;Insomnia;Lipodystrophy acquired;Loss of personal independence in daily activities;Nephrolithiasis;Osteopenia;Pain;Pain in extremity;Urinary tract infection,203516463,HO,,,203516463,1,2001,2008,,,203516463,1,HIV infection
20353240,203532403,3,F,20120801,20230724,20220119,20230728,EXP,,US-GILEAD-2022-0565864,GILEAD,,55,YR,A,M,Y,48.98,KG,20230728,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Back pain;Blood creatinine increased;Chronic kidney disease;Chronic kidney disease-mineral and bone disorder;Dysstasia;Emotional distress;Gait disturbance;Insomnia;Pain;Pollakiuria;Protein total increased;Renal impairment;Renal injury;Vitamin D deficiency,203532403,HO,,,203532403,1,2010,2010,,,203532403,1,HIV infection
20353321,203533213,3,F,20100101,20230712,20220119,20230717,EXP,,US-GILEAD-2022-0565796,GILEAD,,62,YR,A,F,Y,98.413,KG,20230717,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Bone demineralisation;Bone pain;Emotional distress;Fatigue;Gait disturbance;Osteoporosis;Pain,203533213,OT,,,203533213,1,2015,2015,,,203533213,1,HIV infection
20359529,203595294,4,F,20130601,20230830,20220121,20230906,EXP,,US-GILEAD-2022-0566167,GILEAD,,60,YR,A,M,Y,94.785,KG,20230906,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Emotional distress;Osteopenia;Pain;Renal injury;Skeletal injury;Tooth injury;Tooth loss,203595294,OT,,,203595294,1,20160614,201706,2639,DAY,203595294,1,HIV infection
20359598,203595983,3,F,20070101,20230803,20220121,20230810,EXP,,US-GILEAD-2022-0565669,GILEAD,,,,A,M,Y,127.91,KG,20230810,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Asthenia;Bone demineralisation;Discomfort;Emotional distress;Fatigue;Intervertebral disc protrusion;Lumbar spinal stenosis;Osteoporosis;Pain;Renal impairment;Vitamin D deficiency,203595983,OT,,,203595983,1,2002,2007,,,203595983,1,HIV infection
20359796,203597963,3,F,20190606,20230820,20220121,20230823,EXP,,US-GILEAD-2022-0566034,GILEAD,,66,YR,E,F,Y,41.27,KG,20230823,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Balance disorder;Bone demineralisation;Dysstasia;Emotional distress;Gait disturbance;Musculoskeletal stiffness;Osteopenia;Osteoporosis;Pain,203597963,OT,,,203597963,1,2013,2018,,,203597963,1,HIV infection
20361137,203611374,4,F,20120101,20230911,20220121,20230914,EXP,,US-GILEAD-2022-0565857,GILEAD,,,,A,M,Y,79.365,KG,20230914,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Emotional distress;End stage renal disease;Loss of personal independence in daily activities;Pain;Pneumonia;Renal failure,203611374,HO,,,203611374,1,2004,2012,,,203611374,1,HIV infection
20361222,203612223,3,F,,20230709,20220121,20230712,EXP,,US-GILEAD-2022-0565664,GILEAD,,,,A,F,Y,87.543,KG,20230712,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Chronic kidney disease;Emotional distress;Gait disturbance;General physical health deterioration;Osteopenia;Osteoporosis;Pain,203612223,OT,,,203612223,1,2016,201903,,,203612223,1,HIV infection
20365706,203657063,3,F,20180911,20230710,20220123,20230712,PER,,US-GILEAD-2022-0565899,GILEAD,,60,YR,A,F,Y,65.76,KG,20230712,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Arthropathy;Bone density decreased;Emotional distress;Gait disturbance;Musculoskeletal stiffness;Osteopenia;Pain,,,,,203657063,1,2007,201811,,,203657063,1,HIV infection
20365717,203657173,3,F,20090401,20230803,20220123,20230807,PER,,US-GILEAD-2022-0565891,GILEAD,,43,YR,A,F,Y,92.517,KG,20230807,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back injury;Back pain;Bone demineralisation;Bone density decreased;Chondropathy;Collagen disorder;Depression;Dysstasia;Emotional distress;Gait disturbance;Osteopenia;Pain;Therapeutic response decreased,,,,,203657173,1,2004,2012,,,203657173,1,HIV infection
20367218,203672183,3,F,20120501,20230720,20220123,20230725,EXP,,US-GILEAD-2022-0566537,GILEAD,,54,YR,A,M,Y,70.295,KG,20230725,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone loss;Bone pain;Emotional distress;Fanconi syndrome acquired;Gait disturbance;Pain;Pain in extremity;Renal disorder;Renal impairment;Renal injury,203672183,OT,,,203672183,2,2009,20090722,12,DAY,203672183,1,HIV infection
20367792,203677923,3,F,20030101,20230706,20220124,20230712,EXP,,US-GILEAD-2022-0565861,GILEAD,,,,A,M,Y,77.098,KG,20230712,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Blood glucose increased;Chronic kidney disease;Diabetes mellitus;Emotional distress;Glomerular filtration rate decreased;Pain;Protein urine present;Renal failure;Renal injury,203677923,OT,,,203677923,1,2001,2004,,,203677923,1,HIV infection
20368213,203682133,3,F,20110101,20230824,20220124,20230830,EXP,,US-GILEAD-2022-0566426,GILEAD,,,,A,M,Y,61.23,KG,20230830,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Bone loss;Emotional distress;Multiple fractures;Osteoporosis;Pain;Renal injury,203682133,OT,,,203682133,1,2009,,,,203682133,1,HIV infection
20371223,203712233,3,F,20150301,20230802,20220124,20230807,EXP,,US-GILEAD-2022-0566467,GILEAD,,50,YR,A,F,Y,73.016,KG,20230807,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone demineralisation;Depression;Emotional distress;Foot fracture;Gait disturbance;Multiple fractures;Osteoporosis;Pain;Pain in extremity;Proteinuria;Renal injury,203712233,OT,,,203712233,1,2005,201906,,,203712233,1,HIV infection
20372264,203722643,3,F,20090515,20230809,20220124,20230814,EXP,,US-GILEAD-2022-0566378,GILEAD,,47,YR,A,F,Y,50.794,KG,20230814,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Bone demineralisation;Dysstasia;Emotional distress;Fall;Gait disturbance;Hand fracture;Multiple fractures;Musculoskeletal stiffness;Osteopenia;Osteoporosis;Pain;Rib fracture,203722643,OT,,,203722643,1,2008,2018,,,203722643,1,HIV infection
20381594,203815943,3,F,20140801,20230815,20220127,20230818,EXP,,US-GILEAD-2022-0566436,GILEAD,,59,YR,A,M,Y,96.599,KG,20230818,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone demineralisation;Emotional distress;Osteoporosis;Pain,203815943,OT,,,203815943,1,2006,201701,,,203815943,1,HIV infection
20454381,204543813,3,F,20140101,20230727,20220210,20230802,EXP,,US-GILEAD-2022-0569129,GILEAD,,,,E,M,Y,63.5,KG,20230802,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Emotional distress;Exercise tolerance decreased;Muscle atrophy;Pain,204543813,OT,,,204543813,1,2014,201509,,,204543813,1,HIV infection
20456758,204567583,3,F,20130524,20230726,20220210,20230728,EXP,,US-GILEAD-2022-0569475,GILEAD,,55,YR,A,F,Y,108.84,KG,20230728,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Emotional distress;Mobility decreased;Osteopenia;Osteoporosis;Pain;Skeletal injury,204567583,OT,,,204567583,1,2006,201608,,,204567583,1,HIV infection
20456852,204568522,2,F,20100601,20230831,20220210,20230907,EXP,,US-GILEAD-2022-0569362,GILEAD,,50,YR,A,M,Y,,,20230907,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;End stage renal disease;Hyperkalaemia;Metabolic acidosis;Pain;Renal impairment;Secondary hyperthyroidism,204568522,DE,,,204568522,1,2003,201002,,,204568522,1,HIV infection
20472918,204729184,4,F,20160101,20230811,20220215,20230815,EXP,,US-GILEAD-2022-0569202,GILEAD,,,,A,M,Y,73.469,KG,20230815,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Chronic kidney disease;Emotional distress;General physical health deterioration;Glomerular filtration rate abnormal;Haematuria;Hypertension;Muscle spasms;Pain;Renal impairment;Renal injury,204729184,OT,,,204729184,1,2004,201708,,,204729184,1,HIV infection
20472920,204729203,3,F,20160101,20230802,20220215,20230807,PER,,US-GILEAD-2022-0569537,GILEAD,,,,A,M,Y,79.378,KG,20230807,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Emotional distress;Gait disturbance;Haematuria;Hypotension;Mobility decreased;Pain;Renal impairment;Urinary tract disorder,204729203,OT,,,204729203,1,2006,2018,,,204729203,1,HIV infection
20474775,204747752,2,F,,20230721,20220215,20230804,EXP,,US-VIIV HEALTHCARE LIMITED-US2022AMR024542,VIIV,,,,,,Y,,,20230804,,CN,US,US,SUSTIVA,Blood creatinine increased;Nephropathy;Renal cyst;Renal failure,204747752,OT,,,204747752,1,20170321,20170925,188,DAY,204747752,1,HIV infection
20479188,204791884,4,F,20110101,20230727,20220216,20230802,EXP,,US-GILEAD-2022-0569062,GILEAD,,51,YR,A,M,Y,72.562,KG,20230802,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Back pain;Blood creatinine increased;Bone pain;Chronic kidney disease;Contusion;Depression;Emotional distress;Exercise tolerance decreased;Fatigue;Hand fracture;Hydronephrosis;Osteopenia;Pain;Renal failure;Renal impairment;Skull fracture,204791884,OT,,,204791884,1,2004,2015,,,204791884,1,HIV infection
20481696,204816964,4,F,20130101,20230716,20220216,20230720,EXP,,US-GILEAD-2022-0569327,GILEAD,,70,YR,E,M,Y,93.878,KG,20230720,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Laboratory test abnormal;Pain;Renal impairment,204816964,OT,,,204816964,1,2004,2016,,,204816964,1,HIV infection
20486717,204867173,3,F,20160101,20230804,20220217,20230807,PER,,US-GILEAD-2022-0569381,GILEAD,,,,A,F,Y,79.819,KG,20230807,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Emotional distress;Osteopenia;Pain;Quality of life decreased,,,,,204867173,1,2007,201707,,,204867173,1,HIV infection
20491985,204919853,3,F,20090101,20230724,20220218,20230725,PER,,US-GILEAD-2022-0569392,GILEAD,,,,A,M,Y,83.9,KG,20230725,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone demineralisation;Dysstasia;Emotional distress;Muscle spasms;Musculoskeletal stiffness;Osteopenia;Pain;Posture abnormal;Skeletal injury;Tooth loss;Wrist fracture,,,,,204919853,1,2008,2008,,,204919853,1,HIV infection
20569252,205692523,3,F,20090101,20230710,20220308,20230714,EXP,,US-GILEAD-2022-0572407,GILEAD,,,,A,F,Y,,,20230714,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Depression;Emotional distress;Mobility decreased;Multiple fractures;Osteoporosis;Pain,205692523,OT,,,205692523,1,2007,2018,,,205692523,1,HIV infection
20570145,205701454,4,F,20130101,20230901,20220309,20230906,EXP,,US-GILEAD-2022-0572815,GILEAD,,50,YR,A,M,Y,99.79,KG,20230906,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Condition aggravated;Emotional distress;Pain;Renal failure,205701454,HO,,,205701454,1,2001,2008,,,205701454,1,HIV infection
20570688,205706883,3,F,20150701,20230811,20220309,20230815,EXP,,US-GILEAD-2022-0572922,GILEAD,,40,YR,A,M,Y,92.971,KG,20230815,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Arthralgia;Blood creatinine increased;Depression;Dysstasia;Emotional distress;Osteopenia;Osteoporosis;Pain;Renal impairment,205706883,OT,,,205706883,1,2002,201612,,,205706883,1,HIV infection
20575030,205750303,3,F,20180101,20230926,20220310,20230928,EXP,,US-GILEAD-2022-0573075,GILEAD,,,,A,M,Y,,,20230928,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone demineralisation;Chronic kidney disease;Emotional distress;Osteopenia;Pain;Renal impairment,205750303,OT,,,205750303,1,2006,201710,,,205750303,1,HIV infection
20579632,205796324,4,F,20120101,20230717,20220310,20230720,EXP,,US-GILEAD-2022-0572733,GILEAD,,,,A,M,Y,132.88,KG,20230720,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Hypertension;Insomnia;Nausea;Nocturia;Pain;Renal impairment,205796324,HO,,,205796324,1,2001,2002,,,205796324,1,HIV infection
20586647,205866473,3,F,20150601,20230815,20220313,20230818,EXP,,US-GILEAD-2022-0572813,GILEAD,,47,YR,A,M,Y,102.04,KG,20230818,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Emotional distress;Multiple fractures;Osteopenia;Pain;Rib fracture,205866473,OT,,,205866473,1,2004,2006,,,205866473,1,HIV infection
20591743,205917432,2,F,,20230731,20220314,20230807,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-036994,BRISTOL MYERS SQUIBB,"Ragni MV, Majerus E, Giermasz A, Fong S, Yates B, Scheeler S, et al. Valoctocogene roxaparvovec gene transfer in participants with HIV. Haemophilia. 2022 Feb 01;28(Suppl 1):101-2.",,,,M,Y,,,20230807,,HP,US,US,EFAVIRENZ,Drug interaction;Hepatocellular injury,205917432,OT,,,,,,,,,205917432,1,HIV infection
20649018,206490184,4,F,20130101,20230807,20220329,20230809,EXP,,US-GILEAD-2022-0575268,GILEAD,,,,A,M,Y,63.492,KG,20230809,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Bone pain;Emotional distress;Exercise tolerance decreased;Foot fracture;Multiple fractures;Osteonecrosis;Osteoporosis;Pain,206490184,OT,,,206490184,1,2005,2013,,,206490184,1,HIV infection
20729008,207290083,3,F,20130101,20230926,20220420,20230928,EXP,,US-GILEAD-2022-0578505,GILEAD,,,,A,M,Y,120,KG,20230928,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone demineralisation;Compression fracture;Emotional distress;Femur fracture;Foot fracture;Hip fracture;Humerus fracture;Osteoporosis;Pain;Rib fracture;Shoulder fracture;Spinal fracture,207290083,OT,,,207290083,1,2006,201710,,,207290083,1,HIV infection
20729777,207297774,4,F,20120601,20230912,20220420,20230918,EXP,,US-GILEAD-2022-0578508,GILEAD,,51,YR,A,M,Y,94.331,KG,20230918,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain;Renal impairment;Vitamin D deficiency,207297774,OT,,,207297774,1,2007,2018,,,207297774,1,HIV infection
20732933,207329333,3,F,20201001,20230725,20220420,20230728,EXP,,US-GILEAD-2022-0578571,GILEAD,,54,YR,A,M,Y,57.143,KG,20230728,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Pain;Renal failure,207329333,OT,,,207329333,1,2016,,,,207329333,1,HIV infection
20858432,208584326,6,F,,20230905,20220521,20230911,EXP,,CA-009507513-2205CAN005476,MERCK,,54,YR,,M,Y,,,20230911,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208584326,HO,,,,,,,,,208584326,1,HIV infection
20859131,208591313,3,F,20120101,20230807,20220523,20230810,EXP,,US-GILEAD-2022-0582477,GILEAD,,57,YR,A,F,Y,103.86,KG,20230810,,LW,US,US,SUSTIVA,Abdominal pain lower;Anhedonia;Anxiety;Arthralgia;Back pain;Bone demineralisation;Depression;Emotional distress;Muscular weakness;Osteonecrosis;Osteoporosis;Pain;Pain in extremity;Periarthritis;Quality of life decreased,208591313,OT,,,208591313,1,2005,201703,,,208591313,1,HIV infection
20859984,208599843,3,F,,20230911,20220523,20230914,EXP,,US-GILEAD-2022-0582560,GILEAD,,,,A,M,Y,99.79,KG,20230914,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Chronic kidney disease;Emotional distress;Insomnia;Pain;Pollakiuria,208599843,OT,,,208599843,1,2014,2009,,,208599843,1,HIV infection
20864521,208645214,4,F,20160301,20230710,20220524,20230714,EXP,,US-GILEAD-2022-0582426,GILEAD,,55,YR,A,M,Y,109.75,KG,20230714,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Bone density decreased;Carotid artery disease;Chronic kidney disease;Constipation;Dysstasia;Emotional distress;Erectile dysfunction;Gait disturbance;Impaired work ability;Loss of personal independence in daily activities;Pain,208645214,OT,,,208645214,1,2014,201908,,,208645214,1,HIV infection
20877650,208776504,4,F,,20230713,20220526,20230725,EXP,,CA-APOTEX-2022AP008239,APOTEX,,54,YR,,M,Y,,,20230725,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208776504,HO,,,,,,,,,208776504,1,HIV infection
20993425,209934257,7,F,,20230731,20220622,20230808,EXP,,CA-JNJFOC-20220629261,JOHNSON AND JOHNSON,,54,YR,A,M,Y,,,20230808,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,209934257,HO,,,,,,,,,209934257,1,Depression
21163633,211636337,7,F,20180112,20220915,20220802,20230804,EXP,,GB-ABBVIE-22P-167-4487400-00,ABBVIE,,16,WK,,M,Y,,,20230804,,HP,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Cleft lip and palate;Exposure during pregnancy;Foetal exposure during pregnancy;Hepatic cytolysis;Hydrops foetalis;Intentional product use issue;Off label use;Trisomy 18;Ultrasound antenatal screen,211636337,CA,,,211636337,9,20171006,20180205,122,DAY,211636337,1,Foetal exposure during pregnancy
21194880,211948802,2,F,,20230913,20220810,20230921,EXP,,CA-AstraZeneca-2022A277353,ASTRAZENECA,,54,YR,,M,Y,,,20230921,,MD,CA,,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,211948802,HO,,,,,,,,,211948802,1,Depression
21217347,212173472,2,F,20220101,20230802,20220816,20230808,PER,,US-SA-2022SA332953,SANOFI AVENTIS,,56,YR,A,F,Y,,,20230809,,MD,US,US,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Injection site pain,,,,,212173472,1,20220427,,,,212173472,1,Dermatitis atopic
21265092,212650922,2,F,20170822,20230804,20220829,20230818,EXP,,ZA-CIPLA LTD.-2022ZA05102,CIPLA,,,,,,Y,,,20230818,,HP,ZA,ZA,EFAVIRENZ,Abortion spontaneous;Exposure during pregnancy,212650922,OT,,,212650922,1,20170224,,,,212650922,1,HIV infection
21269614,212696142,2,F,,20230818,20220830,20230824,EXP,,CA-BAUSCH-BL-2022-021010,BAUSCH AND LOMB,,,,,M,Y,,,20230824,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction,212696142,HO,,,,,,,,,212696142,1,Product used for unknown indication
21280548,212805482,2,F,,20230818,20220901,20230828,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2022GSK125136,VIIV,,,,,,Y,,,20230828,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,212805482,OT,,,,,,,,,212805482,1,HIV infection
21280558,212805582,2,F,,20230818,20220901,20230828,EXP,,CA-GSK-CA2022GSK125136,GLAXOSMITHKLINE,,,,,,Y,,,20230828,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,212805582,DE,,,,,,,,,212805582,1,HIV infection
21303387,213033872,2,F,,20230704,20220907,20230719,EXP,,CA-MYLANLABS-2022M1091917,MYLAN,,,,,M,Y,,,20230719,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction,213033872,HO,,,,,,,,,213033872,1,Product used for unknown indication
21306338,213063383,3,F,20210618,20230829,20220908,20230909,EXP,,ES-AUROBINDO-AUR-APL-2022-032121,AUROBINDO,,22,YR,,M,Y,,,20230909,,MD,ES,ES,EFAVIRENZ,Off label use;Treatment noncompliance;Virologic failure,213063383,OT,,,213063383,2,20220218,20220218,246,DAY,213063383,1,HIV infection
21411803,214118037,7,F,,20230816,20221005,20230825,EXP,,CA-MYLANLABS-2022M1110802,MYLAN,,54,YR,,M,Y,,,20230825,,HP,CA,CA,EFAVIRENZ,Anxiety;Depression suicidal;Depressive symptom;Drug interaction;Off label use;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,214118037,HO,,,214118037,1,2007,,,,214118037,1,Bipolar disorder
21439002,214390022,2,F,20210618,20230913,20221011,20230919,EXP,,ES-MYLANLABS-2022M1096222,MYLAN,,22,YR,,M,Y,,,20230919,,MD,ES,ES,EFAVIRENZ,Off label use;Treatment noncompliance;Virologic failure,,,,,214390022,2,20210618,20220218,246,DAY,214390022,1,HIV infection
21532531,215325313,3,F,,20230803,20221101,20230817,EXP,,IN-CIPLA (EU) LIMITED-2022IN06312,CIPLA,"Lad SG, Pandey V, Kolhe K, Chauhan S, Gattani M, Sethiya P et.al. AIH in HIV: A Very Much Possible Entity. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY. 2022;12 (5):1388 to 1392",,,,,Y,,,20230817,,HP,IN,IN,EFAVIRENZ,Autoimmune hepatitis;Drug-induced liver injury,215325313,OT,,,,,,,,,215325313,1,HIV infection
21542652,215426522,2,F,20150101,20230905,20221102,20230906,PER,,US-GILEAD-2022-0603542,GILEAD,,,,A,M,Y,,,20230906,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Emotional distress;Hypertension;Pain,,,,,215426522,1,2004,201805,,,215426522,1,HIV infection
21549976,215499764,4,F,,20230203,20221103,20230828,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-2022-128597,BRISTOL MYERS SQUIBB,"Aksak-Was BJ, Leszczyszyn-Pynka M, Parczewski M, Krzysztalowski A. Interdisciplinary management of multidrug-resistant tuberculosis in an HIV-infected patient: case report. HIV and AIDS Review. 2017 Oct 13;16(3):198-203.doi:10.5114/hivar.2017.70947.",43,YR,A,M,Y,,,20230828,,HP,PL,PL,EFAVIRENZ,Blood bilirubin increased;Clostridium difficile colitis;Conductive deafness;Diarrhoea;Drug ineffective;Drug resistance;Hepatitis cholestatic;Lymphopenia;Myalgia;Nausea;Neuropsychiatric symptoms;Neutropenia;Pancreatitis;Pathogen resistance;Urinary tract infection;Urinary tract inflammation,215499764,OT,,,215499764,1,2011,,,,215499764,1,Acquired immunodeficiency syndrome
21554065,215540652,2,F,20201001,20230719,20221104,20230724,EXP,,US-GILEAD-2022-0603518,GILEAD,,58,YR,A,M,Y,76,KG,20230724,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Emotional distress;Gait disturbance;Osteopenia;Osteoporosis;Pain;Tenosynovitis stenosans,215540652,OT,,,215540652,1,2012,202201,,,215540652,1,HIV infection
21557666,215576665,5,F,20120101,20230824,20221106,20230904,EXP,,PL-JNJFOC-20221056107,JOHNSON AND JOHNSON,,43,YR,A,M,Y,,,20230904,,HP,PL,PL,EFAVIRENZ,Blood bilirubin increased;Clostridium difficile colitis;Conductive deafness;Diarrhoea;Drug resistance;Hepatitis cholestatic;Lymphopenia;Mental disorder;Myalgia;Nausea;Neuropsychiatric symptoms;Neutropenia;Pancreatitis;Pathogen resistance;Urinary tract infection;Urinary tract inflammation,215576665,HO,,,215576665,3,2011,,,,215576665,1,Acquired immunodeficiency syndrome
21583026,215830264,4,F,,20230728,20221111,20230809,EXP,CA-MHPD-E2B_05617673,CA-Accord-284705,ACCORD,,54,YR,A,M,Y,,,20230809,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,215830264,OT,,,,,,,,,215830264,1,Depression
21691095,216910954,4,F,20130101,20230726,20221207,20230728,EXP,,US-GILEAD-2022-0607706,GILEAD,,,,A,M,Y,99.79,KG,20230728,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Back pain;Blood creatinine increased;Bone density abnormal;Bone density decreased;Chronic kidney disease;Emotional distress;Pain;Tooth loss,216910954,OT,,,216910954,1,2007,2011,,,216910954,1,HIV infection
21738852,217388522,2,F,,20230717,20221216,20230731,EXP,,US-CIPLA LTD.-2022US07155,CIPLA,"Kilcrease C, Agwu AL, Yusuf H, Park J, Powell A, James L et al.. Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series. AIDS Research and Therapy. 2022;19 (56):1 to 6",,,,,Y,,,20230731,,HP,US,US,EFAVIRENZ,Adverse drug reaction;Drug resistance;Immunosuppression;Infection;Mucocutaneous candidiasis;Nausea;Onychomycosis;Oral candidiasis;Pneumonia;Product use complaint;Pyelonephritis;Somnolence;Treatment noncompliance;Varicella;Virologic failure,217388522,OT,,,,,,,,,217388522,1,HIV infection
21844859,218448593,3,F,20120201,20230906,20230110,20230912,PER,,US-GILEAD-2023-0611875,GILEAD,,48,YR,A,M,Y,,,20230912,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Pain;Renal failure;Renal impairment,218448593,OT,,,218448593,1,2014,201202,,,218448593,1,HIV infection
21892749,218927492,2,F,20190101,20230731,20230120,20230802,EXP,,US-GILEAD-2023-0613231,GILEAD,,57,YR,A,M,Y,77.1,KG,20230802,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Clavicle fracture;Emotional distress;Foot fracture;Osteopenia;Osteoporosis;Pain,218927492,OT,,,218927492,1,2006,2005,,,218927492,1,HIV infection
21892932,218929323,3,F,20080601,20230831,20230120,20230906,PER,,US-GILEAD-2023-0613298,GILEAD,,46,YR,A,M,Y,97.52,KG,20230906,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Gait disturbance;Pain;Renal impairment,218929323,OT,,,218929323,1,2010,201812,,,218929323,1,HIV infection
21893014,218930142,2,F,20120101,20230821,20230120,20230825,EXP,,US-GILEAD-2023-0613315,GILEAD,,,,A,M,Y,72,KG,20230825,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Depression;Emotional distress;Foot fracture;Gait disturbance;Osteoporosis;Pain,218930142,OT,,,218930142,1,2001,2011,,,218930142,1,HIV infection
21901036,219010363,3,F,20051001,20230907,20230123,20230912,PER,,US-GILEAD-2023-0613355,GILEAD,,38,YR,A,M,Y,57.596,KG,20230912,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Hypertension;Malaise;Pain;Pyrexia;Renal failure;Renal tubular necrosis;Weight decreased,219010363,HO,,,219010363,1,2001,200510,,,219010363,1,HIV infection
21901292,219012922,2,F,20111101,20230712,20230123,20230718,EXP,,US-GILEAD-2023-0613431,GILEAD,,46,YR,A,M,Y,63.502,KG,20230718,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatine increased;Chronic kidney disease;Emotional distress;Pain,219012922,OT,,,219012922,1,2006,200801,,,219012922,1,HIV infection
21901298,219012983,3,F,20140101,20230705,20230123,20230710,EXP,,US-GILEAD-2023-0613437,GILEAD,,59,YR,A,M,Y,,,20230710,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Emotional distress;End stage renal disease;Pain;Renal failure,219012983,HO,,,219012983,1,2007,201308,,,219012983,1,HIV infection
21901336,219013363,3,F,20060101,20230817,20230123,20230823,PER,,US-GILEAD-2023-0613337,GILEAD,,,,A,M,Y,,,20230823,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Drug ineffective;Emotional distress;End stage renal disease;Fatigue;Hypertension;Loss of personal independence in daily activities;Nephrogenic anaemia;Pain;Pollakiuria;Poor quality sleep;Renal failure;Sexual dysfunction,219013363,HO,,,219013363,1,2001,,,,219013363,1,HIV infection
21903570,219035702,2,F,,20230629,20230124,20230821,EXP,,CA-MYLANLABS-2023M1006793,MYLAN,,54,YR,,M,Y,,,20230821,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,219035702,DS,,,,,,,,,219035702,1,Bipolar disorder
22045722,220457222,2,F,,20230809,20230228,20230817,EXP,,CA-009507513-2302CAN007234,MERCK,,54,YR,,M,Y,,,20230817,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,220457222,HO,,,,,,,,,220457222,1,Product used for unknown indication
22058305,220583052,2,F,,20230803,20230303,20230817,EXP,,CO-CIPLA LTD.-2023CO01159,CIPLA,"Ardila-Suarez OM, Oriz-Benjumea L, Arteta AA, Guevara-Casallas LG. Drug-induced liver injury: Relation between the R ratio and histopathology. Journal of Gastroenterology of Mexico. 2023;88 (1):19 to 27",,,,,Y,,,20230817,,HP,CO,CO,EFAVIRENZ,Chronic hepatitis;Drug-induced liver injury;Hepatocellular injury,220583052,OT,,,,,,,,,220583052,1,HIV infection
22063544,220635442,2,F,,20230803,20230306,20230817,EXP,,CO-CIPLA LTD.-2023CO01160,CIPLA,"Ardila-Suarez OM, Oriz-Benjumea L, Arteta AA, Guevara-Casallas LG.. Drug-induced liver injury: Relation between the R ratio and histopathology.. Journal of Gastroenterology of Mexico. 2023;88 (1):19 to 27",,,,,Y,,,20230817,,HP,CO,CO,EFAVIRENZ,Chronic hepatitis;Drug-induced liver injury;Hepatocellular injury,220635442,HO,,,,,,,,,220635442,1,HIV infection
22066492,220664922,2,F,,20230803,20230306,20230817,EXP,,CO-CIPLA LTD.-2023CO01161,CIPLA,"Ardila-Suarez OM, Oriz-Benjumea L, Arteta AA, Guevara-Casallas LG. Drug-induced liver injury: Relation between the R ratio and histopathology. Journal of Gastroenterology of Mexico. 2023;88 (1):19 to 27",,,,,Y,,,20230817,,HP,CO,CO,EFAVIRENZ,Drug-induced liver injury;Mixed liver injury,220664922,OT,,,,,,,,,220664922,1,HIV infection
22227500,222275002,2,F,20170901,20230804,20230419,20230818,EXP,,ZA-CIPLA (EU) LIMITED-2023ZA02014,CIPLA,"Khan A, Pillay M, Chimukangara B, Gounder L, Manyana S, Francois KL et al.. Identification of HIV-1 subtype CRF18_cpx in a patient with multidrug resistance in KwaZulu-Natal, South Africa: An epidemiological worry?. Journal of Clinical Virology Plus. 2023;1 to 7",,,,,Y,,,20230818,,HP,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Diarrhoea;Multiple-drug resistance;Normochromic normocytic anaemia;Treatment noncompliance;Virologic failure,222275002,HO,,,222275002,1,20170109,20181204,694,DAY,222275002,1,HIV infection
22298122,222981222,2,F,,20230901,20230509,20230905,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107208,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20230905,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Hospitalisation;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222981222,HO,,,,,,,,,222981222,1,HIV infection
22313066,223130664,4,F,,20230630,20230512,20230704,EXP,,JP-GILEAD-2023-0627751,GILEAD,,8,DEC,E,F,Y,35,KG,20230704,,PH,JP,JP,EFAVIRENZ,Femoral neck fracture;Rectal perforation;Tubulointerstitial nephritis,223130664,OT,,,,,,,,,223130664,1,HIV infection
22618751,226187512,2,F,,20230703,20230620,20230710,EXP,IT-ViiV Healthcare Limited-IT2023GSK079465,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-243515",BOEHRINGER INGELHEIM,"Labate L, Bruzzone B, Spagnuolo V, Zazzi M, Santoro MM, Di Biagio A et al. Prestigio ring: ?A 59-year-old HIV-1 positive, highly treatment-experienced women failing darunavir/ritonavir plus raltegravir.^. The New Microbiologica. 2023;46(2):226-230",59,YR,A,F,Y,150,KG,20230710,,HP,IT,IT,EFAVIRENZ,Immune system disorder;Insomnia;Neuropathy peripheral;Pathogen resistance;Toxicity to various agents;Viral mutation identified;Virologic failure,226187512,OT,,,226187512,1,19990505,20000120,260,DAY,226187512,1,HIV infection
22627955,226279552,2,F,,20230628,20230622,20230710,EXP,,VN-MYLANLABS-2023M1064470,MYLAN,"Doan thu T, Do duy C.. Changes in liver enzymes and glomerular filtration rate in persons with hiv/aids after antiretroviral treatment at the center for tropical diseases, bach mai hospital. VIETNAM MEDICAL JOURNAL. 2023;2:526",,,,,Y,,,20230710,,HP,VN,VN,EFAVIRENZ,Glomerular filtration rate decreased;Hepatic enzyme increased,226279552,OT,,,,,,,,,226279552,1,Acquired immunodeficiency syndrome
22630049,226300492,2,F,,20230713,20230622,20230719,EXP,,CA-GILEAD-2023-0633371,GILEAD,,54,YR,A,M,Y,,,20230719,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226300492,HO,,,,,,,,,226300492,1,Product used for unknown indication
22630182,226301824,4,F,20220101,20230704,20230622,20230712,EXP,,IT-JNJFOC-20230631223,JOHNSON AND JOHNSON,,59,YR,A,F,Y,150,KG,20230712,,HP,IT,IT,EFAVIRENZ,Immune system disorder;Immunodeficiency;Insomnia;Multiple drug therapy;Neuropathy peripheral;Pathogen resistance;Toxicity to various agents;Treatment failure;Treatment noncompliance;Viral mutation identified;Virologic failure,226301824,OT,,,226301824,3,20040402,20080321,473,DAY,226301824,1,HIV infection
22651632,226516322,2,F,,20230831,20230628,20230907,EXP,,CA-MYLANLABS-2019M1132176,MYLAN,,54,YR,,M,Y,,,20230907,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Labelled drug-drug interaction medication error;Psychiatric decompensation,226516322,OT,,,,,,,,,226516322,1,Product used for unknown indication
22662018,226620182,2,F,20100112,20230720,20230630,20230727,EXP,,GB-009507513-1101GBR00090B1,MERCK,,0,YR,,,Y,2.45,KG,20230727,,HP,GB,GB,EFAVIRENZ,Foetal exposure during pregnancy;Low birth weight baby,226620182,OT,,,226620182,1,20100922,20160112,,,,,
22662983,226629832,2,F,20131227,20230823,20230703,20230830,EXP,,JP-JNJFOC-20181027661,JOHNSON AND JOHNSON,,49,YR,A,M,Y,,,20230830,,MD,JP,JP,EFAVIRENZ,Amoebic dysentery;Beta 2 microglobulin urine increased;Irritable bowel syndrome;Protein urine present,226629832,OT,,,226629832,1,20121018,20181231,7,YR,226629832,1,HIV infection
22663153,226631532,2,F,20220101,20230626,20230703,20230710,EXP,,IT-AUROBINDO-AUR-APL-2023-044527,AUROBINDO,"Labate L, Bruzzone B, Spagnuolo V, Zazzi M, Santoro MM, Di Biagio a, et al... PRESTIGIO RING: ^A 59-year-old HIV-1 positive, highly treatment-experienced woman failing darunavir/ ritonavir plus raltegravir^. The new microbiologica.. 2023;46 (2):226-30",59,YR,,F,Y,43,KG,20230710,,HP,IT,IT,EFAVIRENZ,Immune system disorder;Insomnia;Multiple drug therapy;Neuropathy peripheral;Pathogen resistance;Toxicity to various agents;Treatment noncompliance;Viral mutation identified;Virologic failure,226631532,OT,,,226631532,1,20080321,20080605,76,DAY,226631532,1,HIV infection
22663827,226638271,1,I,,20230621,20230703,20230703,EXP,,GB-AUROBINDO-AUR-APL-2023-044641,AUROBINDO,,,,,F,Y,,,20230703,,HP,GB,GB,EFAVIRENZ,Neurotoxicity,226638271,OT,,,,,,,,,226638271,1,Product used for unknown indication
22664503,226645031,1,I,,20230621,20230703,20230703,EXP,,GB-MACLEODS PHARMACEUTICALS US LTD-MAC2023042129,MACLEODS,,,,,,Y,,,20230703,,HP,GB,GB,EFAVIRENZ,Neurotoxicity,226645031,OT,,,,,,,,,226645031,1,Product used for unknown indication
22666415,226664151,1,I,,20230621,20230703,20230703,EXP,,SE-VIIV HEALTHCARE LIMITED-SE2023GSK088940,VIIV,"Elvstam O, Malmborn K, Elen S, Marrone G, Garcia F, Zazzi M et al. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort. Clinical Infectious Diseases. 2023;76(1):25-31",,,,,Y,,,20230703,,HP,SE,SE,EFAVIRENZ,HIV viraemia,226664151,OT,,,,,,,,,226664151,1,HIV infection
22666416,226664161,1,I,,20230621,20230703,20230703,EXP,,SE-GSK-SE2023GSK088940,GLAXOSMITHKLINE,"Elvstam O, Malmborn K, Elen S, Marrone G, Garcia F, Zazzi M et al. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort. Clinical Infectious Diseases. 2023;76(1):25-31",,,,,Y,,,20230703,,HP,SE,SE,EFAVIRENZ,HIV viraemia,226664161,OT,,,,,,,,,226664161,1,HIV infection
22667420,226674201,1,I,,20230627,20230704,20230704,EXP,,CA-009507513-2306CAN013580,MERCK,,54,YR,,M,Y,,,20230704,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226674201,HO,,,,,,,,,226674201,1,HIV infection
22671193,226711931,1,I,,20230621,20230705,20230705,EXP,,GB-CIPLA LTD.-2023GB03475,CIPLA,,,,,,Y,,,20230705,,HP,GB,GB,EFAVIRENZ,Neurotoxicity,226711931,OT,,,,,,,,,226711931,1,Product used for unknown indication
22672016,226720161,1,I,,20230627,20230705,20230705,EXP,,CA-AstraZeneca-2023A151283,ASTRAZENECA,,54,YR,,M,Y,,,20230705,,MD,CA,,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226720161,HO,,,,,,,,,226720161,1,Depression
22672219,226722191,1,I,,20230628,20230705,20230705,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-092636,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20230705,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Hospitalisation;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226722191,OT,,,,,,,,,226722191,1,HIV infection
22676416,226764161,1,I,20230417,20230614,20230706,20230706,EXP,,RU-GSK-RU2023EME088178,GLAXOSMITHKLINE,,,,,,Y,,,20230706,,CN,RU,RU,EFAVIRENZ,Anaemia;Blood pressure increased;Cerebral haematoma;Cerebral haemorrhage;Haemorrhagic stroke;Hemiataxia;Hypertension;Subarachnoid haemorrhage,226764161,HO,,,226764161,1,20141027,20150205,101,DAY,226764161,1,HIV infection
22676417,226764171,1,I,20230417,20230614,20230706,20230706,EXP,,RU-VIIV HEALTHCARE LIMITED-RU2023EME088178,VIIV,,,,,,Y,,,20230706,,CN,RU,RU,EFAVIRENZ,Anaemia;Blood pressure increased;Cerebral haematoma;Cerebral haemorrhage;Haemorrhagic stroke;Hemiataxia;Hypertension;Subarachnoid haemorrhage,226764171,HO,,,226764171,1,20141027,20150205,101,DAY,226764171,1,HIV infection
22676605,226766051,1,I,,20230626,20230706,20230706,EXP,,CA-TEVA-2023-CA-2903695,TEVA,,54,YR,A,M,Y,,,20230706,,HP,CA,CA,EFAVIRENZ,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,226766051,DE,,,,,,,,,226766051,1,Bipolar disorder
22676695,226766951,1,I,,20230626,20230706,20230706,EXP,,CA-TEVA-2023-CA-2904043,TEVA,,44,YR,A,M,Y,,,20230706,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226766951,OT,,,,,,,,,226766951,1,HIV infection
22680635,226806351,1,I,20230526,20230703,20230707,20230707,EXP,FR-AFSSAPS-TS2023000845,FR-BRISTOL-MYERS SQUIBB COMPANY-2023-094446,BRISTOL MYERS SQUIBB,,78,YR,E,M,Y,72,KG,20230707,,MD,FR,FR,EFAVIRENZ,Retinopathy,226806351,OT,,,226806351,1,20001001,20140312,4910,DAY,226806351,1,HIV infection
22686456,226864561,1,I,20230526,20230705,20230710,20230710,EXP,FR-AFSSAPS-TS2023000845,FR-VIIV HEALTHCARE LIMITED-FR2023092168,VIIV,,,,,,Y,,,20230710,,MD,FR,FR,EFAVIRENZ,Retinopathy,226864561,OT,,,226864561,1,20001001,20150325,5288,DAY,226864561,1,HIV infection
22686474,226864741,1,I,20230526,20230705,20230710,20230710,EXP,FR-AFSSAPS-TS2023000845,FR-GSK-FR2023092168,GLAXOSMITHKLINE,,,,,,Y,,,20230710,,MD,FR,FR,EFAVIRENZ,Retinopathy,226864741,OT,,,226864741,1,20001001,20150325,5288,DAY,226864741,1,HIV infection
22687920,226879201,1,I,,20230629,20230710,20230710,EXP,,GB-MYLANLABS-2023M1070629,MYLAN,,,,,M,Y,,,20230710,,CN,GB,GB,EFAVIRENZ,Cerebrovascular accident;Hemiplegia,226879201,HO,,,,,,,,,226879201,1,HIV infection
22692568,226925681,1,I,,20230704,20230711,20230711,EXP,,IN-MYLANLABS-2023M1073099,MYLAN,"Lad SG, Kolhe K, Chauhan S, Gattani M, Sethiya P, Singh GK, et al. AIH in HIV: A Very Much Possible Entity. J-Clin-Exp-Hepatol 2022;12(5):1388-1392.",48,YR,,F,Y,,,20230711,,MD,IN,IN,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Acute kidney injury;Anaemia,226925681,OT,,,,,,,,,226925681,1,HIV infection
22693568,226935681,1,I,,20230704,20230711,20230711,EXP,,TH-MYLANLABS-2023M1073833,MYLAN,"Anuroj K, Chongbanyatcharoen S, Chiencharoenthanakij R. Severe Anemia: A Case Report of an Uncommon Precipitant of Schizophrenia Relapse. J-Blood-Med 2023;14:329-336.",48,YR,,F,Y,,,20230711,,HP,TH,TH,EFAVIRENZ,Anaemia;Intentional product misuse;Schizophrenia;Treatment noncompliance;Vitamin B12 deficiency,226935681,HO,,,226935681,1,2020,202206,,,226935681,1,HIV infection
22694160,226941601,1,I,20220101,20230710,20230711,20230711,EXP,FR-AFSSAPS-RS2023000486,FR-BRISTOL-MYERS SQUIBB COMPANY-2023-097466,BRISTOL MYERS SQUIBB,,72,YR,E,M,Y,,,20230711,,MD,FR,FR,EFAVIRENZ,Drug interaction;Hyperthyroidism,226941601,OT,,,226941601,1,2013,202201,,,226941601,1,HIV infection
22695997,226959971,1,I,,20230704,20230712,20230712,EXP,,TH-STRIDES ARCOLAB LIMITED-2023SP011199,STRIDES,"Anuroj K, Chongbanyatcharoen S, Chiencharoenthanakij R.. Severe Anemia: A Case Report of an Uncommon Precipitant of Schizophrenia Relapse.. J-Blood-Med. 2023;14:329-336",48,YR,,F,Y,,,20230712,,HP,TH,TH,EFAVIRENZ,Intentional product misuse;Off label use;Treatment noncompliance;Vitamin B12 deficiency,226959971,HO,,,226959971,1,2022,202206,,,226959971,1,Dyspepsia
22696312,226963121,1,I,,20230703,20230712,20230712,EXP,,US-MYLANLABS-2023M1072590,MYLAN,"Lopez A, Bacha J, Kovarik C, Campbell L. Successful use of multidisciplinary palliative care in the outpatient treatment of disseminated histoplasmosis in an hiv positive child. Children-(Basel) 2021;8(4):no pagination.",10,YR,,F,Y,,,20230712,,HP,US,US,EFAVIRENZ,Drug ineffective,226963121,OT,,,,,,,,,226963121,1,HIV infection
22699078,226990781,1,I,,20230630,20230713,20230713,EXP,,SE-AUROBINDO-AUR-APL-2023-046499,AUROBINDO,"Elvstam O, Malmborn K, Elen S, Marrone G, Garcia F, Zazzi M et al.. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort. Clinical Infectious Diseases. 2023;76(1):25-31",,,A,,Y,,,20230713,,HP,SE,SE,EFAVIRENZ,HIV viraemia,226990781,OT,,,,,,,,,226990781,1,HIV infection
22699553,226995531,1,I,,20230629,20230713,20230713,EXP,,IN-MACLEODS PHARMA EU LTD-MAC2023042282,MACLEODS,"Sridhar S, Sangumani J.. Highly Active Antiretroviral Therapy-associated Lipodystrophy: Pseudo-Cushing^s Syndrome. The Journal of the Association of Physicians of India. 2023;71(2):11-12",,,,,Y,,,20230713,,HP,IN,IN,EFAVIRENZ,Cushing's syndrome;Dyslipidaemia;Lipodystrophy acquired,226995531,OT,,,,,,,,,226995531,1,HIV infection
22714660,227146601,1,I,,20230706,20230718,20230718,EXP,,GB-AUROBINDO-AUR-APL-2023-047489,AUROBINDO,,,,,M,Y,,,20230718,,CN,GB,GB,EFAVIRENZ,Cerebrovascular accident;Hemiplegia,227146601,HO,,,,,,,,,227146601,1,HIV infection
22714911,227149111,1,I,,20230710,20230718,20230718,EXP,,IN-HETERO-HET2023IN02036,HETERO,"Lad SG, Kolhe K, Chauhan S, Gattani M, Sethiya P, Singh GK, et al.. AIH in HIV: A Very Much Possible Entity. Journal of Clinical and Experimental Hepatology.. 2022;12(5):1388-1392",48,YR,,F,Y,,,20230718,,HP,IN,IN,EFAVIRENZ,Acute kidney injury,227149111,OT,,,,,,,,,227149111,1,HIV infection
22722094,227220942,2,F,,20230711,20230719,20230719,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP011546,STRIDES,"Kilcrease C, Yusuf H, Park J, Powell A, Rn LJ, Rn JO, et al.. Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series.. AIDS-Res-Ther. 2022;19(1)",,,,F,Y,,,20230719,,HP,US,US,EFAVIRENZ,Intentional product misuse;Treatment noncompliance;Virologic failure,227220942,OT,,,,,,,,,227220942,1,Perinatal HIV infection
22726133,227261331,1,I,,20230710,20230720,20230720,EXP,,IN-HETERO-HET2023IN02037,HETERO,"Lad S G,Kolhe K, Chauhan S,Gattani M,Sethiya P,Singh G K et al. AIH in HIV: A Very Much Possible Entity. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY. 2022;12:1388-1392",42,YR,,F,Y,,,20230720,,HP,IN,IN,EFAVIRENZ,Autoimmune hepatitis;Drug-induced liver injury,227261331,OT,,,,,,,,,227261331,1,HIV infection
22728690,227286901,1,I,,20230719,20230720,20230720,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-2023-102263,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20230720,,CN,GB,GB,EFAVIRENZ,Cerebrovascular accident;Hemiplegia,227286901,HO,,,,,,,,,227286901,1,HIV infection
22734045,227340451,1,I,,20230711,20230721,20230721,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP011619,STRIDES,"Kilcrease C, Yusuf H, Park J, Powell A, Rn LJ, n JO, et al.. Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series.. AIDS-Res-Ther. 2022;19 (1)",,,,F,Y,,,20230721,,HP,US,US,EFAVIRENZ,Intentional product misuse;Treatment noncompliance;Virologic failure,227340451,OT,,,,,,,,,227340451,1,Perinatal HIV infection
22739450,227394501,1,I,20220101,20230710,20230722,20230722,EXP,,FR-AUROBINDO-AUR-APL-2023-047837,AUROBINDO,,72,YR,,M,Y,,,20230722,,MD,FR,FR,EFAVIRENZ,Drug interaction;Hyperthyroidism,227394501,OT,,,227394501,1,2013,202201,,,227394501,1,HIV infection
22739852,227398521,1,I,,20230710,20230722,20230722,EXP,,CA-AUROBINDO-AUR-APL-2023-048696,AUROBINDO,"Lopez A, Bacha J, Kovarik C, Campbell L. Successful use of multidisciplinary palliative care in the outpatient treatment of disseminated histoplasmosis in an hiv positive child. Children-(Basel). 2021;8(4)",10,YR,,F,Y,,,20230723,,HP,CA,CA,EFAVIRENZ,Drug ineffective,227398521,OT,,,,,,,,,227398521,1,HIV infection
22745383,227453831,1,I,,20230713,20230725,20230725,EXP,,CA-APOTEX-2023AP010583,APOTEX,,54,YR,,M,Y,,,20230725,,HP,CA,CA,EFAVIRENZ,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,227453831,HO,,,,,,,,,227453831,1,HIV infection
22745671,227456711,1,I,,20230719,20230725,20230725,EXP,,CA-ABBVIE-5338005,ABBVIE,,54,YR,,M,Y,,,20230725,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,227456711,HO,,,,,,,,,227456711,1,Depression
22752200,227522001,1,I,,20230719,20230726,20230726,EXP,,GB-VIIV HEALTHCARE LIMITED-ZA2023GSK099979,VIIV,"Kemp SA, Charles OJ, Derache A, Smidt W, Martin DP, Iwuji C et al. HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy. mBio. 2022;13 (3)",,,,,Y,,,20230726,,HP,GB,ZA,EFAVIRENZ,Antiviral drug level below therapeutic;Pathogen resistance;Treatment failure;Treatment noncompliance;Viraemia;Viral mutation identified;Virologic failure,227522001,OT,,,,,,,,,227522001,1,HIV infection
22752201,227522011,1,I,,20230719,20230726,20230726,EXP,,GB-GSK-ZA2023GSK099979,GLAXOSMITHKLINE,"Kemp SA, Charles OJ, Derache A, Smidt W, Martin DP, Iwuji C et al. HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy. mBio. 2022;13 (3)",,,,,Y,,,20230726,,HP,GB,ZA,EFAVIRENZ,Antiviral drug level below therapeutic;Pathogen resistance;Treatment failure;Treatment noncompliance;Viraemia;Viral mutation identified;Virologic failure,227522011,OT,,,,,,,,,227522011,1,HIV infection
22770988,227709881,1,I,,20230724,20230801,20230801,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012365,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11",,,A,M,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Anaemia,227709881,OT,,,,,,,,,227709881,1,HIV infection
22770990,227709901,1,I,,20230724,20230801,20230801,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012291,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One.. 2022;17(3):1-11",,,A,F,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227709901,OT,,,,,,,,,227709901,1,HIV infection
22771012,227710121,1,I,,20230724,20230801,20230801,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012363,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11",,,A,M,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227710121,OT,,,,,,,,,227710121,1,HIV infection
22771104,227711041,1,I,,20230724,20230801,20230801,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012324,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One.. 2022;17(3):1-11",,,A,F,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Anaemia,227711041,OT,,,,,,,,,227711041,1,HIV infection
22771661,227716611,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1080981,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Anaemia;Nervous system disorder,227716611,OT,,,,,,,,,227716611,1,HIV infection
22771667,227716671,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1080980,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230801,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Treatment failure,227716671,OT,,,,,,,,,227716671,1,HIV infection
22771669,227716691,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1081024,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Treatment failure,227716691,OT,,,,,,,,,227716691,1,HIV infection
22771670,227716701,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1080995,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Treatment failure,227716701,OT,,,,,,,,,227716701,1,HIV infection
22771830,227718301,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1080944,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Treatment failure,227718301,OT,,,,,,,,,227718301,1,HIV infection
22771831,227718311,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1080957,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227718311,OT,,,,,,,,,227718311,1,HIV infection
22771832,227718321,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1081101,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Treatment failure,227718321,OT,,,,,,,,,227718321,1,HIV infection
22773857,227738571,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1081027,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230801,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Treatment failure,227738571,OT,,,,,,,,,227738571,1,HIV infection
22773866,227738661,1,I,,20230724,20230801,20230801,EXP,,ET-MYLANLABS-2023M1081055,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230801,,HP,ET,ET,EFAVIRENZ,Treatment failure,227738661,OT,,,,,,,,,227738661,1,HIV infection
22774471,227744711,1,I,,20230719,20230802,20230802,EXP,,GB-AUROBINDO-AUR-APL-2023-050100,AUROBINDO,,,,,M,Y,,,20230802,,HP,GB,GB,EFAVIRENZ,Cerebrovascular accident;Hemiplegia,227744711,HO,,,,,,,,,227744711,1,HIV infection
22774512,227745121,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012401,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One.. 2022;17(3):1-11",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227745121,OT,,,,,,,,,227745121,1,HIV infection
22774515,227745151,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012362,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227745151,OT,,,,,,,,,227745151,1,HIV infection
22774518,227745181,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012290,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One.. 2022;17(3):1-11",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Maternal exposure during pregnancy,227745181,OT,,,,,,,,,227745181,1,HIV infection
22774885,227748851,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012422,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Nervous system disorder,227748851,OT,,,,,,,,,227748851,1,HIV infection
22774936,227749361,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012393,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Nervous system disorder,227749361,OT,,,,,,,,,227749361,1,HIV infection
22775804,227758041,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012380,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227758041,OT,,,,,,,,,227758041,1,HIV infection
22775818,227758181,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012432,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One.. 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227758181,OT,,,,,,,,,227758181,1,HIV infection
22775845,227758451,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012400,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Nervous system disorder,227758451,OT,,,,,,,,,227758451,1,HIV infection
22775857,227758571,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012409,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Nervous system disorder,227758571,OT,,,,,,,,,227758571,1,HIV infection
22775883,227758831,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012270,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227758831,OT,,,,,,,,,227758831,1,HIV infection
22775952,227759521,1,I,,20230724,20230802,20230802,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012374,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227759521,OT,,,,,,,,,227759521,1,HIV infection
22776056,227760561,1,I,,20230723,20230802,20230802,EXP,,IN-HETERO-HET2023IN02166,HETERO,"Singh B, Guliani A, Hanumanthu V, Narang T, Dogra S, Handa S et.al. A prospective study to estimate the incidence and pattern of adverse drug reactions to first-line antiretroviral therapy (tenofovir, efavirenz, and lamivudine). Indian Journal of Sexually Transmitted Diseases and AIDS. 2023;44(1):6-10",,,,M,Y,,,20230802,,HP,IN,IN,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Drug reaction with eosinophilia and systemic symptoms,227760561,OT,,,,,,,,,227760561,1,HIV infection
22776214,227762141,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081066,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Treatment failure,227762141,OT,,,,,,,,,227762141,1,HIV infection
22776215,227762151,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081166,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227762151,OT,,,,,,,,,227762151,1,HIV infection
22776216,227762161,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1080947,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227762161,OT,,,,,,,,,227762161,1,HIV infection
22776220,227762201,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081108,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Treatment failure,227762201,OT,,,,,,,,,227762201,1,HIV infection
22776225,227762251,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081179,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Treatment failure,227762251,OT,,,,,,,,,227762251,1,HIV infection
22776226,227762261,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1080959,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Maternal exposure during pregnancy,227762261,OT,,,,,,,,,227762261,1,HIV infection
22776227,227762271,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081185,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227762271,OT,,,,,,,,,227762271,1,HIV infection
22776228,227762281,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081061,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227762281,OT,,,,,,,,,227762281,1,HIV infection
22776233,227762331,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1080988,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Treatment failure,227762331,OT,,,,,,,,,227762331,1,HIV infection
22776234,227762341,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1080970,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227762341,OT,,,,,,,,,227762341,1,HIV infection
22776515,227765151,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081152,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Treatment failure,227765151,OT,,,,,,,,,227765151,1,HIV infection
22777293,227772931,1,I,20230508,20230801,20230802,20230802,EXP,,DE-TAKEDA-2023TUS075156,TAKEDA,,,,A,M,Y,,,20230802,,HP,DE,DE,EFAVIRENZ,Haematuria,227772931,OT,,,227772931,1,20190107,20211227,38,DAY,227772931,1,Factor VIII deficiency
22778542,227785421,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081155,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227785421,OT,,,,,,,,,227785421,1,HIV infection
22778543,227785431,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081051,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227785431,OT,,,,,,,,,227785431,1,HIV infection
22778544,227785441,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081189,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Anaemia,227785441,OT,,,,,,,,,227785441,1,HIV infection
22778549,227785491,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081083,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227785491,OT,,,,,,,,,227785491,1,HIV infection
22778550,227785501,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081007,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227785501,OT,,,,,,,,,227785501,1,HIV infection
22778551,227785511,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1080993,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Nervous system disorder;Treatment failure,227785511,OT,,,,,,,,,227785511,1,HIV infection
22778552,227785521,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081085,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Treatment failure,227785521,OT,,,,,,,,,227785521,1,HIV infection
22778553,227785531,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081190,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Anaemia,227785531,OT,,,,,,,,,227785531,1,HIV infection
22778554,227785541,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081081,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,F,Y,,,20230802,,HP,ET,ET,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Maternal exposure during pregnancy;Treatment failure,227785541,OT,,,,,,,,,227785541,1,HIV infection
22778761,227787611,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081058,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Treatment failure,227787611,OT,,,,,,,,,227787611,1,HIV infection
22778763,227787631,1,I,,20230724,20230802,20230802,EXP,,ET-MYLANLABS-2023M1081201,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230802,,HP,ET,ET,EFAVIRENZ,Treatment failure,227787631,OT,,,,,,,,,227787631,1,HIV infection
22780101,227801011,1,I,,20230724,20230803,20230803,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012430,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11",,,A,F,Y,,,20230803,,HP,ET,ET,EFAVIRENZ,Nervous system disorder,227801011,OT,,,,,,,,,227801011,1,HIV infection
22780117,227801171,1,I,,20230724,20230803,20230803,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012268,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One. 2022;17(3):1-11.",,,A,F,Y,,,20230803,,HP,ET,ET,EFAVIRENZ,Nervous system disorder,227801171,OT,,,,,,,,,227801171,1,HIV infection
22781039,227810391,1,I,,20230724,20230803,20230803,EXP,,ET-STRIDES ARCOLAB LIMITED-2023SP012428,STRIDES,"Fentie Wendie T, Mengistu G.. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.. PLOS-One.. 2022;17(3):1-11",,,A,F,Y,,,20230803,,HP,ET,ET,EFAVIRENZ,Nervous system disorder,227810391,OT,,,,,,,,,227810391,1,HIV infection
22781139,227811391,1,I,,20230724,20230803,20230803,EXP,,ET-MYLANLABS-2023M1081116,MYLAN,"Fentie Wendie T, Mengistu G. Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study. PLOS-One 2022;17(3):1-11.",,,A,M,Y,,,20230803,,HP,ET,ET,EFAVIRENZ,Anaemia;Treatment failure,227811391,OT,,,,,,,,,227811391,1,HIV infection
22787611,227876112,2,F,20220401,20230809,20230804,20230816,EXP,,TH-JNJFOC-20230761960,JOHNSON AND JOHNSON,,48,YR,A,F,Y,,,20230817,,HP,TH,TH,EFAVIRENZ,Condition aggravated;Inflammation;Metabolic disorder;Schizophrenia,227876112,OT,,,227876112,1,2014,202206,,,227876112,1,Schizophrenia
22788872,227888721,1,I,,20230727,20230804,20230804,EXP,CA-Health Canada-000982831,CA-ABBVIE-2217864US,ABBVIE,,54,YR,,M,Y,,,20230804,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,227888721,HO,,,,,,,,,227888721,1,Psychotic disorder
22796430,227964302,2,F,20220401,20230809,20230808,20230821,EXP,TH-VIIV HEALTHCARE LIMITED-TH2023GSK064336,TH-JUBILANT CADISTA PHARMACEUTICALS-2023TH000858,JUBILANT,"Anuroj K, Chongbanyatcharoen S, Chiencharoenthanakij R.. Severe Anemia: A Case Report of an Uncommon Precipitant of Schizophrenia Relapse. Journal of Blood Medicine. 2023;14:329-36",48,YR,,F,Y,,,20230821,,MD,TH,TH,EFAVIRENZ,Aplasia pure red cell;Aplastic anaemia;Autoimmune haemolytic anaemia;Condition aggravated;Inflammation;Metabolic disorder;Schizophrenia,227964302,OT,,,227964302,1,2014,202206,,,227964302,1,Schizophrenia
22797484,227974841,1,I,20210601,20230731,20230808,20230808,EXP,,ES-VIIV HEALTHCARE LIMITED-ES2023GSK105024,VIIV,"Knobel H, Canas-Ruano E, Guelar A, Knobel P, Villar-Garcia J, Gonzalez-Mena A et al. Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study. HIV Research and Clinical Practice. 2023;24 (1)",,,,,Y,,,20230808,,HP,ES,ES,EFAVIRENZ,Insomnia;Pathogen resistance;Treatment noncompliance;Viral mutation identified;Virologic failure,227974841,OT,,,227974841,1,202012,202012,,,227974841,1,HIV infection
22797491,227974911,1,I,20210601,20230731,20230808,20230808,EXP,,ES-GSK-ES2023GSK105024,GLAXOSMITHKLINE,"Knobel H, Canas-Ruano E, Guelar A, Knobel P, Villar-Garcia J, Gonzalez-Mena A et al. Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study. HIV Research and Clinical Practice. 2023;24 (1)",,,,,Y,,,20230808,,HP,ES,ES,EFAVIRENZ,Insomnia;Pathogen resistance;Treatment noncompliance;Viral mutation identified;Virologic failure,227974911,OT,,,227974911,1,202012,202012,,,227974911,1,HIV infection
22818216,228182161,1,I,,20230731,20230814,20230814,EXP,,IN-CIPLA LTD.-2023IN04773,CIPLA,,,,,,Y,,,20230814,,HP,IN,IN,EFAVIRENZ,Foetal exposure during pregnancy;Neural tube defect,228182161,CA,,,,,,,,,,,
22818822,228188221,1,I,,20230731,20230814,20230814,EXP,,ZA-CIPLA (EU) LIMITED-2023ZA04764,CIPLA,,,,,,Y,,,20230814,,HP,ZA,ZA,EFAVIRENZ,Abortion spontaneous;Exposure during pregnancy,228188221,OT,,,,,,,,,228188221,1,Antiretroviral therapy
22821496,228214962,2,F,,20230822,20230814,20230829,EXP,,US-MYLANLABS-2023M1085726,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",37,YR,,F,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228214962,OT,,,,,,,,,228214962,1,HIV infection
22826740,228267402,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085746,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",36,YR,,M,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267402,OT,,,,,,,,,228267402,1,HIV infection
22826742,228267421,1,I,,20230807,20230816,20230816,EXP,,US-MYLANLABS-2023M1085697,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",,,,,Y,,,20230816,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267421,OT,,,,,,,,,228267421,1,HIV infection
22826743,228267432,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085700,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",33,YR,,F,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267432,OT,,,,,,,,,228267432,1,HIV infection
22826745,228267451,1,I,,20230807,20230816,20230816,EXP,,US-MYLANLABS-2023M1085744,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",,,,,Y,,,20230816,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267451,OT,,,,,,,,,228267451,1,HIV infection
22826746,228267462,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085739,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",34,YR,,M,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267462,OT,,,,,,,,,228267462,1,HIV infection
22826747,228267472,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085698,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",39,YR,,F,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267472,OT,,,,,,,,,228267472,1,HIV infection
22826748,228267482,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085702,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",26,YR,,F,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267482,OT,,,,,,,,,228267482,1,HIV infection
22826750,228267501,1,I,,20230807,20230816,20230816,EXP,,US-MYLANLABS-2023M1085735,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",,,,,Y,,,20230816,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267501,OT,,,,,,,,,228267501,1,HIV infection
22826752,228267521,1,I,,20230807,20230816,20230816,EXP,,US-MYLANLABS-2023M1085695,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",,,,,Y,,,20230816,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267521,OT,,,,,,,,,228267521,1,HIV infection
22826755,228267552,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085713,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",43,YR,,M,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267552,OT,,,,,,,,,228267552,1,HIV infection
22826759,228267592,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085699,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",40,YR,,M,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267592,OT,,,,,,,,,228267592,1,HIV infection
22826792,228267921,1,I,,20230807,20230816,20230816,EXP,,US-MYLANLABS-2023M1085709,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",,,,,Y,,,20230816,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267921,OT,,,,,,,,,228267921,1,HIV infection
22826793,228267932,2,F,,20230822,20230816,20230830,EXP,,US-MYLANLABS-2023M1085761,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",52,YR,,F,Y,,,20230830,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228267932,OT,,,,,,,,,228267932,1,HIV infection
22827213,228272132,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085728,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",47,YR,,F,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228272132,OT,,,,,,,,,228272132,1,HIV infection
22827214,228272142,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085730,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",39,YR,,F,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228272142,OT,,,,,,,,,228272142,1,HIV infection
22827216,228272162,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085743,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",47,YR,,F,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228272162,OT,,,,,,,,,228272162,1,HIV infection
22827220,228272202,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085708,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",49,YR,,F,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228272202,OT,,,,,,,,,228272202,1,HIV infection
22827307,228273072,2,F,,20230822,20230816,20230829,EXP,,US-MYLANLABS-2023M1085715,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",38,YR,,M,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228273072,OT,,,,,,,,,228273072,1,HIV infection
22827704,228277042,2,F,,20230822,20230816,20230828,EXP,,US-MYLANLABS-2023M1085755,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",52,YR,,F,Y,,,20230828,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228277042,OT,,,,,,,,,228277042,1,HIV infection
22831518,228315183,3,F,,20230822,20230817,20230829,EXP,,US-MYLANLABS-2023M1085732,MYLAN,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, et al. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS 2022;36(14):2057-2062.",35,YR,,M,Y,,,20230829,,HP,US,ZA,EFAVIRENZ,Drug ineffective,228315183,OT,,,,,,,,,228315183,1,HIV infection
22843222,228432221,1,I,,20230811,20230821,20230821,EXP,,US-PADAGIS-2023PAD01162,PADAGIS,"Latef JT, Bhardwajb P,Bilalc M. Refractory acquired haemophilia A in a patient with HIV treated with Emicizumab. Blood Coagulation and Fibrinolysis. 2022;33(2):138-140",,,,,Y,,,20230821,,MD,US,US,EFAVIRENZ + EMTRICITABINE + TENOFOVIR [EFAVIRENZ;EMTRICITABINE;TENOFOV,Depression;Product use in unapproved indication;Somnolence,,,,,,,,,,,228432221,1,Acquired haemophilia
22848888,228488881,1,I,,20230809,20230822,20230822,EXP,,CA-AUROBINDO-AUR-APL-2023-054100,AUROBINDO,,54,YR,,M,Y,,,20230822,,HP,CA,CA,EFAVIRENZ,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,228488881,HO,,,,,,,,,228488881,1,Psychotic disorder
22872934,228729341,1,I,,20230821,20230828,20230828,EXP,,GB-GILEAD-2023-0640941,GILEAD,"Ali M, Lee N, French P, Miller R and Ahmed N. Effective prolonged suppression of HIV-1 viral load using tenofovir alafenamide, emtricitabine and efavirenz in an adult with BMI }59 kg/m2. International Journal of STD + AIDS. 2023;0 (0):1-3. doi:https://doi.org/10.1177/09564624231195088",59,YR,A,F,Y,,,20230828,,HP,GB,GB,EFAVIRENZ,Acute kidney injury;Diabetic ketoacidosis,228729341,OT,,,228729341,1,2019,,,,228729341,1,HIV infection
22875985,228759851,1,I,,20230823,20230829,20230829,EXP,,US-VIIV HEALTHCARE LIMITED-KE2023GSK116810,VIIV,,,,,,Y,,,20230829,,HP,US,KE,EFAVIRENZ,Pathogen resistance;Viral mutation identified;Virologic failure,228759851,OT,,,,,,,,,228759851,1,HIV infection
22875990,228759901,1,I,,20230823,20230829,20230829,EXP,,US-VIIV HEALTHCARE LIMITED-KE2023GSK116811,VIIV,,,,,,Y,,,20230829,,HP,US,KE,EFAVIRENZ,Pathogen resistance;Viral mutation identified;Virologic failure,228759901,OT,,,,,,,,,228759901,1,HIV infection
22875993,228759931,1,I,,20230823,20230829,20230829,EXP,,US-GSK-KE2023GSK116811,GLAXOSMITHKLINE,,,,,,Y,,,20230829,,HP,US,KE,EFAVIRENZ,Pathogen resistance;Viral mutation identified;Virologic failure,228759931,OT,,,,,,,,,228759931,1,HIV infection
22875994,228759941,1,I,,20230823,20230829,20230829,EXP,,US-GSK-KE2023GSK116810,GLAXOSMITHKLINE,,,,,,Y,,,20230829,,HP,US,KE,EFAVIRENZ,Pathogen resistance;Viral mutation identified;Virologic failure,228759941,OT,,,,,,,,,228759941,1,HIV infection
22892383,228923831,1,I,20230802,20230829,20230901,20230901,EXP,,UA-MYLANLABS-2023M1091767,MYLAN,,55,YR,,M,Y,,,20230901,,HP,UA,UA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Creatinine renal clearance decreased,228923831,LT,,,228923831,1,20211123,20230803,619,DAY,228923831,1,HIV infection
22913082,229130821,1,I,,20230904,20230906,20230906,EXP,,ZA-ORGANON-O2309ZAF000846,ORGANON,,,,,F,Y,,,20230906,,MD,ZA,ZA,EFAVIRENZ,Pregnancy with implant contraceptive;Unintended pregnancy,229130821,OT,,,,,,,,,229130821,1,Contraception
22923668,229236681,1,I,,20230828,20230908,20230908,EXP,,US-APOTEX-2023AP013349,APOTEX,"Clowse MEB, Rajendran A, Eudy A, Giattino S, Swaminathan A, James AH.. Pregnancy Outcomes in Patients With Interstitial Lung Disease. Arthritis Care + Research. 2023;75(5):1166-1174",,,A,F,Y,,,20230908,,MD,US,US,EFAVIRENZ,Maternal exposure during pregnancy,229236681,OT,,,,,,,,,229236681,1,Teratogenicity
22944890,229448901,1,I,,20230907,20230914,20230914,EXP,,CN-GSK-CN2023GSK123510,GLAXOSMITHKLINE,"Li J, Wen Z, Chen Y, Yin S. R263K Mutation Leading to Failure of Dolutegravir-Based Treatment in a HIV Patient also Receiving Rifampicin A Case Report. Re:GEN Open. 2023;3 (1):34-39",,,,,Y,,,20230914,,HP,CN,CN,EFAVIRENZ,Cough;Drug interaction;Haemoptysis;Night sweats;Pathogen resistance;Productive cough;Treatment failure;Viral mutation identified;Virologic failure;Weight decreased,229448901,OT,,,229448901,1,20191021,20210128,465,DAY,229448901,1,HIV infection
22944901,229449011,1,I,,20230907,20230914,20230914,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2023GSK123510,VIIV,"Li J, Wen Z, Chen Y, Yin S. R263K Mutation Leading to Failure of Dolutegravir-Based Treatment in a HIV Patient also Receiving Rifampicin A Case Report. Re:GEN Open. 2023;3 (1):34-39",,,,,Y,,,20230914,,HP,CN,CN,EFAVIRENZ,Cough;Drug interaction;Haemoptysis;Night sweats;Pathogen resistance;Productive cough;Treatment failure;Viral mutation identified;Virologic failure;Weight decreased,229449011,OT,,,229449011,1,20191021,20210128,465,DAY,229449011,1,HIV infection
22947191,229471911,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058424,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057?2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229471911,OT,,,,,,,,,229471911,1,HIV infection
22947250,229472501,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058429,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057?2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229472501,OT,,,,,,,,,229472501,1,HIV infection
22947357,229473571,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058434,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057-2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229473571,OT,,,,,,,,,229473571,1,HIV infection
22947459,229474591,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058435,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057?2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229474591,OT,,,,,,,,,229474591,1,HIV infection
22947501,229475011,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058437,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229475011,OT,,,,,,,,,229475011,1,HIV infection
22947542,229475421,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058438,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229475421,OT,,,,,,,,,229475421,1,HIV infection
22947546,229475461,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058441,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057?2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229475461,OT,,,,,,,,,229475461,1,HIV infection
22947709,229477091,1,I,,20230831,20230915,20230915,EXP,,CA-MYLANLABS-2023M1092612,MYLAN,,54,YR,,M,Y,,,20230915,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,229477091,OT,,,,,,,,,229477091,1,Bipolar disorder
22947825,229478251,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058421,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057?2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229478251,OT,,,,,,,,,229478251,1,HIV infection
22947850,229478501,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058426,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229478501,OT,,,,,,,,,229478501,1,HIV infection
22947916,229479161,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058430,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057?2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229479161,OT,,,,,,,,,229479161,1,HIV infection
22947995,229479951,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058440,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057-2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229479951,OT,,,,,,,,,229479951,1,HIV infection
22948390,229483901,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058431,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229483901,OT,,,,,,,,,229483901,1,HIV infection
22948414,229484141,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058436,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229484141,OT,,,,,,,,,229484141,1,HIV infection
22948417,229484171,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058422,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens.. AIDS. 2022;36(14):2057-2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229484171,OT,,,,,,,,,229484171,1,HIV infection
22948432,229484321,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058427,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229484321,OT,,,,,,,,,229484321,1,HIV infection
22948445,229484451,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058432,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229484451,OT,,,,,,,,,229484451,1,HIV infection
22948456,229484561,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058439,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057-2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229484561,OT,,,,,,,,,229484561,1,HIV infection
22949145,229491451,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058425,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229491451,OT,,,,,,,,,229491451,1,HIV infection
22949152,229491521,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058423,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057?2062",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229491521,OT,,,,,,,,,229491521,1,HIV infection
22949153,229491531,1,I,,20230904,20230915,20230915,EXP,,ZA-AUROBINDO-AUR-APL-2023-058442,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14)",,,,,Y,,,20230915,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective;Virologic failure,229491531,OT,,,,,,,,,229491531,1,HIV infection
22950719,229507191,1,I,,20230904,20230916,20230916,EXP,,ZA-AUROBINDO-AUR-APL-2023-058428,AUROBINDO,"van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Gandhi M, et al.. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS. 2022;36 (14):2057-2062",,,,,Y,,,20230916,,HP,ZA,ZA,EFAVIRENZ,Drug ineffective,229507191,OT,,,,,,,,,229507191,1,HIV infection
22964190,229641902,2,F,,20230918,20230921,20230929,EXP,,CN-GILEAD-2023-0643503,GILEAD,"Tang J , Liu Y. A Case Report of Efavirenz Induced Gynecomastia. Chinese Journal of Pharmacovigilance. 2023;unk:unk. doi:10.19803/j.1672- 8629.20230041",72,YR,E,M,Y,,,20230929,,HP,CN,CN,EFAVIRENZ,Gynaecomastia,229641902,HO,,,,,,,,,229641902,1,HIV infection
22967702,229677022,2,F,,20230929,20230921,20230930,EXP,,PL-ABBVIE-5411496,ABBVIE,,43,YR,,M,Y,,,20230930,,HP,PL,PL,EFAVIRENZ,Diarrhoea;Drug ineffective;Drug resistance;Hepatitis cholestatic;Lymphopenia;Myalgia;Nausea;Neuropsychiatric symptoms;Neutropenia;Off label use;Pancreatitis;Pathogen resistance;Urinary tract infection bacterial,229677022,HO,,,229677022,7,201112,,,,229677022,1,HIV infection
22968486,229684861,1,I,20230307,20230914,20230921,20230921,EXP,FR-AFSSAPS-PA2023001711,FR-ELI_LILLY_AND_COMPANY-FR202309008129,ELI LILLY AND CO,,53,YR,,M,Y,95,KG,20230921,,CN,FR,FR,EFAVIRENZ,Neoplasm progression,229684861,OT,,,229684861,1,202207,202303,,,229684861,1,Psoriasis
22969513,229695131,1,I,20200101,20230916,20230922,20230922,EXP,,"ES-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00605",VELOXIS PHARMACEUTICALS,"Corrales A, Unzue L, Llovera L, Cancelo N.. First psychotic episode due to immunosuppressor medication.. European Psychiatry.. 2023;66(Suppl.1):S1047",46,YR,,M,Y,,,20230922,,MD,ES,ES,Abacavir+Lamivudine+Efavirenz,Psychotic disorder,229695131,HO,,,229695131,1,2020,2021,18,YR,229695131,1,Immunosuppressant drug therapy
22970289,229702891,1,I,,20230918,20230922,20230922,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-2023-132965,BRISTOL MYERS SQUIBB,,43,YR,A,M,Y,,,20230922,,HP,PL,PL,EFAVIRENZ,Diarrhoea;Drug resistance;Hepatitis cholestatic;Lymphopenia;Myalgia;Nausea;Neuropsychiatric symptoms;Neutropenia;Pancreatitis;Pathogen resistance;Urinary tract infection,229702891,HO,,,229702891,1,2011,,,,229702891,1,HIV infection
23006300,230063001,1,I,,20230918,20230929,20230929,EXP,,GB-CIPLA LTD.-2023GB05771,CIPLA,"Ali M, Lee N, French P, Miller R, Ahmed N. Effective prolonged suppression of HIV-1 viral load using Tenofovir alafenamide, emtricitabine and efavirenz in an adult with BMI }59 kg/m2. NA",,,,,Y,,,20230929,,HP,GB,GB,EFAVIRENZ,Acute kidney injury;Diabetic ketoacidosis,230063001,OT,,,230063001,1,2019,,,,230063001,1,Antiretroviral therapy
23008626,230086261,1,I,20230830,20230926,20230929,20230929,EXP,,UA-MYLANLABS-2023M1103083,MYLAN,,66,YR,,F,Y,,,20230929,,HP,UA,UA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Nephropathy toxic,230086261,OT,,,230086261,1,20220310,20230830,539,DAY,230086261,1,HIV infection
23011647,230116471,1,I,20110101,20230919,20230929,20230929,EXP,,GB-009507513-2309GBR007192,MERCK,"Obeng L, Patel A, Villa G, Mourad A, Whibley M, Gilleece Y, et al.. Autoimmune hepatitis in people living with HIV: A case series and review of literature. Open AIDS Journal. 2023;17",47,YR,,F,Y,,,20230929,,HP,GB,GB,EFAVIRENZ,Autoimmune hepatitis,230116471,OT,,,230116471,1,201001,201101,,,230116471,1,HIV infection
7609977,760997731,31,F,20061128,20230801,20100928,20230808,EXP,,JP-JNJFOC-20100907113,JOHNSON AND JOHNSON,,49,YR,A,M,Y,,,20230808,,MD,JP,JP,EFAVIRENZ,Anaemia;Drug resistance;Dyslipidaemia;Hepatocellular carcinoma;Hyperbilirubinaemia;Osteoporosis;Pyelonephritis,760997731,HO,,,760997731,1,20061111,20220927,12,YR,760997731,1,HIV infection
